Find a Top Internist Near Me in Sherman, TX – Book an Appointment Instantly

Dr. Berg has received many prestigious awards, including The Medical Book Award (sponsored by Merck Pharmaceuticals) honoring integrity, leadership skills and caring compassion for patients and peers. She has also gained recognition in the Bridges to Excellence program for diabetes care. Dr. Berg's patient say "She is a truly compassionate person and an extremely knowledgeable health care provider. She listens to your concerns, never makes you feel rushed." (Amber C. Health grades)

Dr. Khalida Yasmin leads the medical staff at Premier Wellness Clinics. She brings her years of medical experience to the Little Elm – Frisco communities to provide quality medical services. As an experienced board-certified physician in family medicine, she has the experience and expertise to properly manage and treat both acute and chronic conditions for patients of all ages. Dr. Yasmin is currently seeing new patients.

Dr. Yasmin is actively involved in a number of organizations, allowing her the opportunity to give back and make a difference in the lives of others.

Dr. Yasmin completed her undergraduate from University of Colorado. She obtained her Medical degree from Punjab University, Pakistan. She completed her family medicine training at University of Illinois in Chicago.

She has over 20 years of experience in Family medicine in variety of settings, she did private practice and served as Captain in the American Air Force reserves. Dr. Yasmin also worked in Youth and Family Clinics in Dallas, as well as being affiliated with Parkland Hospital.

She has been very active in state and local medical organizations and served on committees at TAFP and has been President of Dallas Chapter of TAFP.

Family Medicine Services

Dr. Yasmin provides treatment and care for a variety of family medicine services which includes:

• Annual exams
• Well Woman Exams
• Flu shots
• Immunizations
• Patient checkups
• Individualized risk assessments
• Cancer screenings
• School and sports physicals
• Chronic disease care
• General medical care for colds, fevers, infections, and other routine issues
  
  

Education

• Undergraduate – 1979 – University of Colorado
• Medical School – 1983 to 1990 – Rawalpindi Medical College
• Residency – 1995 to 1998 Christ Hospital – Oak Lawn, IL
  
  

License and Certification

• Diplomate of American Board of Family Medicine
  
  

Experience

• Private Practice – 1998 to present
• Air Force Reserves Physician – 1998 to 2007
  
  

Professional Organizations

• American Academy of Family Physicians
• Dallas Chapter President of Texas Academy of Family Physicians
• American Muslim Women Physicians Association
  
  

Professional Committees

• Dallas Chapter TAFP.
• Member of Executive Committee.
• Chair of Ethic Committee at Trinity Medical Center.
• Health Advisory Committee – Carrollton Farmer Branch School District.
• Health Advisory Committee – Islamic Association of North Texas Richardson.
• Member of Public Health Committee TAFP.
• Member of NCSC Committee TAFP.

Mandeep Acharya, MD, has been practicing Internal Medicine in the Dallas–Fort Worth area since 2012. At Texas Primary Care Specialists, located in Frisco, Texas, he looks forward to providing compassionate care and quality service at the highest standards.

Dr. Acharya received his medical degree from Nepalgunj Medical College in Nepal in 2006. He completed his three-year Internal Medicine residency at Presence Saint Joseph Hospital, in Chicago, which is affiliated with the University Of Illinois Chicago.

Dr. Acharya is certified by the American Board of Internal Medicine. 

By incorporating an evidence-based approach to the Art of Medicine, Dr. Acharya provides individualized and highly personalized care to patients. He believes that the human body functions as a whole and a primary care doctor can connect the dots and coordinate the care for a patient with multiple physicians. He strives to prevent the fragmentation of medicine in current care models between hospitals, ERs, urgent care clinics, and specialists to prioritize and emphasize the health goals for his patients. 

To better serve his patients, Dr. Acharya is fluent in English, Nepali, and Hindi.

 

Vini Bapna, MD, is an internal medicine specialist based in Frisco, Texas, committed to providing comprehensive and compassionate care to her patients. Dr. Bapna is thrilled to be part of the team at Texas Primary Care Specialists, where she aspires to foster enduring and healthy patient-provider relationships.

Dr. Bapna's journey in medicine started with her education at SMS Medical College, where she completed her internship training. She completed her residency at Mercy Hospital, where she further honed her expertise in internal medicine and patient care.

As a longstanding resident of Frisco, Dr. Bapna is deeply connected to the community she serves. Her genuine passion for preventative care aligns perfectly with her desire to assist patients in achieving and maintaining optimal health. With a warm and caring approach, she strives to develop strong bonds with her patients, becoming their trusted primary care provider.

Dr. Bapna's commitment to her field is underscored by her specialization in Internal Medicine and Geriatric Medicine. This specialized focus equips her with the knowledge and skills to provide comprehensive care to a diverse range of patients, including seniors.

With a wealth of experience and a dedication to ongoing education and patient-centered care, Dr. Bapna is a valuable asset to Texas Primary Care Specialists. Her role in promoting health, preventing illness, and enhancing the well-being of her patients makes her an integral part of the Frisco community's healthcare landscape.

LANGUAGES:

• Polish (Fluent) 
• Spanish (Conversational)

BOARD CERTIFICATIONS:

• Clinical Cardiac Electrophysiology - Board Eligible
• Cardiovascular Disease
• Internal Medicine

HOSPITALS:

• Baylor Scott & White Medical Center - Plano
• Baylor Scott & White | The Heart Hospital Plano
• Baylor Scott & White | The Heart Hospital Denton
• Baylor University Medical Center
• Baylor Heart & Vascular Hospital - Dallas
• Medfinity Health Plano
• Medical City Frisco
• Medical City Dallas
• Medical City Dallas Heart & Spine Hospital
• Medical City Plano
• Methodist Dallas Medical Center
• North Park Heart & Vascular Center
• Texas Health Allen
• Texas Health Dallas
• Texas Health Frisco
• Texas Health Plano

EDUCATION:

• Fellowship, Clinical Cardiac Electrophysiology: Louisiana State University Health Sciences Center, New Orleans, LA  
• Fellowship, Cardiovascular Disease: Louisiana State University Health Sciences Center, New Orleans, LA  
• Residency, Internal Medicine: University of Arizona College of Medicine, Phoenix, AZ 
• Medical School, MD Degree: Medical University of South Carolina, Charleston, SC 
• Undergraduate, BS in Chemical Engineering: University of South Carolina, Columbia, SC  
• Undergraduate, BS in Chemistry: University of South Carolina, Columbia, SC  
• Undergraduate, Spanish Language Internship: Universidad de Salamanca, Salamanca, Spain, Spanish Language Internship 

PROFESSIONAL ASSOCIATIONS:

• American College of Cardiology
• American College of Physicians
• American Society of Nuclear Cardiology
• American Medical Student Association
• American Medical Association

HONORS/AWARDS:

• Louisiana Chapter ACC FIT Jeopardy: First Place (2020)
• Louisiana Chapter ACC FIT Jeopardy: First Place (2019)
• Resident Research Academic Excellence Day Banner University Medical Center: First Place (2017)
• High Value Competition Award Banner University Medical Center: First Place (2016)
• PGY-1 Poster ACP Arizona Chapter Scientific Meeting: First Place (2015)
• Medical University of South Carolina: Research Grant Awarded (2014)
• University of South Carolina: Dean's List (2002-2007)

PUBLICATIONS:

• Shao, Wanda; Drutel, Robert; Weiss, Jessica; Gerkin, Richard; et al. “QTc Prolongation Associated with Psychiatric Medications: A Retrospective Cross-sectional Study of Adult Behavioral Health Inpatients”. J Clin Psychopharmacol. 2019 Jan/Feb;39(1):72-77.
• Drutel R.; Payne J.; Glancy L. “Bradycardia in a Man with Hypertension”. American Journal of Cardiology. Oct. 2019.
• Jakkoju A.; Drutel R.; Ahmed J.; Cox-Alomar P.; Lelorier P.; Glancy L. “Myocarditis Presenting as Sudden Cardiac Death”. Journal of the Louisiana State Medical Society. 2019.
• Kern J.; Drutel R.; Leanhart S.; Bogacz M.; Pacholczyk R. "Reduction of T cell receptor diversity in NOD mice prevents development of type 1 Diabetes but not Sjögren’s syndrome". PLoS One. 2014 Nov 7;9(11).
• Drutel, R.; Jain, N.; Helmcke, F. “Chemotherapy Responsive Apical Left Ventricular Metastasis from Renal Cell Carcinoma". (2020, Accepted).

BOARD CERTIFICATIONS:

• Clinical Cardiac Electrophysiology
• Cardiovascular Disease

HOSPITALS:

• Baylor Scott & White Heart & Vascular Hospital - Dallas
• Baylor Scott & White | The Heart Hospital Plano
• Baylor University Medical Center
• Medfinity Health Plano
• Medical City Dallas
• Medical City Heart Hospital
• Medical City Frisco
• Medical City Plano
• Methodist Richardson Medical Center
• North Park Heart & Vascular Center
• Texas Health Allen
• Texas Health Frisco
• Texas Health Plano

EDUCATION:

• Fellowship, Clinical Cardiac Electrophysiology: University of Chicago, Chicago, Illinois
• Fellowship, Cardiology: University of Chicago, Chicago, Illinois
• Postdoctoral Research Fellowship, Cardiology: University of Pittsburgh, Pittsburgh, Pennsylvania
• Chief Resident, Internal Medicine:  University of Pittsburgh Medical Center, McKeesport, Pennsylvania
• Residency, Internal Medicine: University of Pittsburgh School of Medicine, McKeesport, Pennsylvania
• Internship, Medicine, Surgery, Pediatrics, and Obstetrics and Gynecology: University College Hospital, Ibadan, Nigeria, Africa
• Medical School, MD Degree:  University of Ibadan, Ibadan, Oyo, Nigeria
• National Diploma: Yaba College of Technology, Lagos, Nigeria, Africa, Major: Electrical/Electronic Engineering

HONORS/AWARDS:

• Guardian Angel Award – University Medical Center Foundation (2018) 
• Best Abstract (Fellow) - Department of Medicine, University of Chicago Research Day (2012) 
• Best Research: Fellow-In-Training Research Day, American College of Cardiology (Illinois Chapter) (2012) 
• Clinical Cardiology Minority Travel Grant, American Heart Association (AHA) (2011) 
• Editorial Team Selection: One of the Must-Read Papers in Noninvasive Cardiac Imaging of the Month, ThePreparedMinds.com (2010)

PROFESSIONAL ASSOCIATIONS:

• Heart Rhythm Society, 2012 - Present
• Heart Rhythm Society, Fellow, 2017 - Present
• Heart Rhythm Society, Associate, 2012 - 2017
• American College of Cardiology, 2010 - Present
• American College of Cardiology, Fellow, 2017 - Present
• American College of Cardiology, Associate, 2010 - 2017

PUBLICATIONS/MEDIA:

Articles and Case Reports - Peer Reviewed ​

• Orellana-Barrios M, Sotello Aviles DA, Oyenuga O, Nugent KM. Implantable cardiac defibrillator infections: The emerging importance of Mycobacterium fortuitum. BMJ Case Rep., September 2017. PubMed Central ID Number: 28928258.

• Adegunsoye A, Levy M, Oyenuga O. Novel therapeutic strategies for reducing right heart failure associated mortality in fibrotic lung diseases. BioMed Research International 16, 2015.

• Onishi T, Onishi T, Marek JJ, Ahmed M, Haberman SC, Oyenuga O, Adelstein E, Schwartzman D, Saba S, Gorcsan J. Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome. Circ Heart Fail, 6(4): 685-93, July 2013. PubMed Central ID Number: 23733917.

• Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White P, Oyenuga O, Onishi T, Soman P, Gorcsan J. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail, 6(3): 427-34, May 2013. PubMed Central ID Number: 23476053.

• Saba S, Schwartzman D, Jain S, Adelstein E, Marek J, White P, Oyenuga O, Soman P, Gorcsan J. Late breaking clinical trials HRS 2012: A prospective randomized controlled study of Echocardiographic-guided Lead Placement for Cardiac Resynchronization Therapy: Results of the STARTER trial. Heart Rhythm Journal, 9(9): 1581-1582, 2012.

• Hara H, Oyenuga O, Tanaka H, Adelstein EC, Onishi T, McNamara DM, Schwartzman D, Saba S, Gorcsan J. The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy. Eur. Heart J., 33(21): 2680-91, November 2012. PubMed Central ID Number: 22351700.
• Oyenuga O, Onishi T, Gorcsan J. A practical approach to imaging dyssynchrony for cardiac resynchronization therapy. Heart Fail Rev, 16(4): 397-410, June 2011. PubMed Central ID Number: 21152974
• Gorcsan J, Oyenuga O, Habib PJ, Tanaka H, Adelstein EC, Hara H, McNamara DM, Saba S. Relationship of echocardiographic dyssynchrony to long-term survival after Cardiac Resynchronization Therapy. Circulation, 122(19): 1910-8, November 2010. PubMed Central ID Number: 20975000.

• Tanaka H, Nesser H-J, Buck T, Oyenuga O, Jánosi RA, Winter S, Saba S, Gorcsan J. Dyssynchrony by speckle-tracking echocardiography and response to Cardiac Resynchronization Therapy: Results of the Speckle Tracking and Resynchronization (STAR) study. Eur. Heart J., 31(14): 1690-700, July 2010. PubMed Central ID Number: 20530502.

• Oyenuga O, Hara H, Tanaka H, Kim H-N, Adelstein EC, Saba S, Gorcsan J. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for Cardiac Resynchronization Therapy. JACC Cardiovasc Imaging, 3(2): 132-40, February 2010. PubMed Central ID Number: 20159638

• Odelola A, Oyenuga O, Ibrahim O, Onasanya O. Gestational trophoblastic disease. Dokita, 28(Reproductive Health Edition 2001): 47-51, 2001.

​

Abstracts - Peer Reviewed

• Beaser AD, Cunnane RT, Ewulonu N, Moss JD, Burke MC, Vatterott PJ, Upadhyay GA, Broman MT, Oyenuga O, Green JJ, Ringwala S, Nayak HM. Degree of ICD lead adherence as assessed by intravascular ultrasound predicts difficulty of extraction. Heart Rhythm Journal, 12(5): AB08-05, May 2015.

• Sparano DM, Ericson K, Cunnane R, Oyenuga O, Sheth H, Burke M, Moss J, Nayak H. Early re-implantation after infected cardiac implantable electronic device extraction is safe and reduces length of stay. Hearth Rhythm Journal, (11): PO03-49, 2014.

• Oyenuga O, Shin JH, Cunnane R, Sparano DM, Sheth H, Nayak HN, Burke M, Moss JD. Prognostic implicaton of tricuspid regurgitation after cardiac resynchronization therapy in preventing progression of heart failure. Hearth Rhythm Journal, (11): PO04-181, 2014.

• Cunnane R, Das A, Moss JD, Nayak HM, Oyenuga O, Sheth H, Sparano DM, Burke M. Single chest X-ray versus multi-angled fluoroscopy in identifying structural abnormalities in riata leads. Heart Rhythm Journal, (11): PO06-27, 2014.

• Marek J, Saba S, Schwartzman D, Jain S, Adelstein EC, Oyenuga O, Onishi T, Gorcsan J. Echo-Guided Lead Placement benefits patients with QRS durations < 150 ms: Results from STARTER randomized controlled trial. Circulation, (126): A11933, 2012.

• Oyenuga O, Onishi T, Onishi T, Haberman SC, Adelstein EC, Saba S, Gorcsan J. Acute reduction in mechanical dyssynchrony by speckle tracking strain after Cardiac Resynchronization Therapy is associated with long term outcome. Circulation, (124): A11337, 2011.

• Hara H, Oyenuga O, Adelstein EC, Schwartzman D, Saba S, Gorcsan J. Electrical reverse remodeling associated with improvements in mechanical dyssynchrony and ventricular function after Cardiac Resynchronization Therapy. Circulation, (124): A11865, 2011.

• Onishi T, Saha SK, Ludwig D, Onishi T, Oyenuga O, Schelbert EB, Schwartzman D, Gorcsan J. Global circumferential strain from routine cardiac magnetic resonance image analysis using a novel off-line approach: Comparison with echocardiographic strain and left ventricular ejection fraction. Circulation, (124): A11953, 2011.

• Hara H, Oyenuga O, Tanaka H, Adelstein EC, McNamara D, Schwartzman D, Saba S, Gorcsan J. Impact of mechanical dyssynchrony on long term outcome in patients with non left bundle branch block after Cardiac Resynchronization Therapy. Circulation, (124): A11834, 2011.

• Onishi T, Onishi T, Oyenuga O, Haberman SC, Saba S, Gorcsan J. Mitral regurgitation with mechanical dyssynchrony as a substrate associated with long-term survival after Cardiac Resynchronization Therapy. Circulation, (124): A9973, 2011.

• Onishi T, Oyenuga O, Haberman SC, Onishi T, Adelstein EC, Saba S, Gorcsan J. The WISE Score: A new index for predicting outcome after Cardiac Resynchronization Therapy using simple clinical data. Circulation, (124): A11338, 2011.

• Onishi T, Haberman SC, Oyenuga O, Onishi T, Tanaka T, Simon M, Champion H, Gorcsan J. Three dimensional speckle tracking strain evaluation of right ventricular mechanics in patients with pulmonary arterial hypertension. Circulation, (124): A11360, 2011.

• Oyenuga O, Onishi T, Onishi T, Haberman SC, Saba S, Gorcsan J. Association of radial dyssynchrony assessed by six-segment standard deviation and long term outcome following Cardiac Resynchronization Therapy. J Am Soc of Echocardiolography, (24): B37, May 2011.

• Onishi T, Oyenuga O, Haberman SC, Onishi T, Adelstein EC, McNamara DM, Gorcsan J. Associations of gender and degree of ventricular dilatation of long term survival after Cardiac Resynchronization Therapy. J Am Soc Echocardiolography, (24): B38, May 2011.

• Haberman SC, Oyenuga O, Adelstein EC, Johnson L, Kim HN, Shroff S, Gorcsan J. The usefulness of a novel automated echocardiographic image analysis program to quantify dyssynchrony and predict long term survival after Cardiac Resynchronization Therapy. J Am Soc of Echocardiolography, (24): B37, May 2011.

• Onishi T, Onishi T, Oyenuga O, Haberman SC, McNamara D, Gorcsan III J. Acute reduction in mitral regurgitation after Cardiac Resynchronization Therapy is associated with favorable long term outcome. J Am College of Cardiology, (57): E350, April 2011.

• Onishi T, Onishi T, Oyenuga O, Haberman SC, Saba S, Gorcsan III J. Acute reduction in post-systolic shortening velocity is associated with response to Cardiac Resynchronization Therapy. J Am College of Cardiology, (57): E866, April 2011.

• Hara H, Oyenuga O, Haberman SC, Adelstein EC, Saba S, Gorcsan III J. Impact of baseline QRS morphology combined with mechanical dyssynchrony on long-term survival after Cardiac Resynchronization Therapy. J Am College of Cardiology, (57): E99, April 2011.

• Onishi T, Habib P, Oyenuga O, Haberman SC, Onishi T, Adelstein E, Saba S, Gorcsan J. Impact of left ventricular volumes on survival following Cardiac Resynchronization Therapy in patients with and without ischemic disease. J Am College of Cardiology, (57): E344, April 2011.

• Onishi T, Onishi T, Oyenuga O, Haberman SC, Saba S, Gorcsan J. Predictors of improvement in mitral regurgitation in heart failure patients following Cardiac Resynchronization Therapy. J Am Society of Echocardiolography, (24): B39, April 2011.

• Oyenuga O, Haberman SC, Onishi T, Onishi T, Adelstein W, Saba S, Gorcsan III J. Which echocardiographic marker of left ventricular response predicts long term survival after resynchronization therapy? J Am College of Cardiology, (57): E102, April 2011.

• Oyenuga O, Habib PJ, Bachman T, Severyn D, Simon M, McNamara DM, Kormos R, Gorcsan J. Global circumferential strain predicts left ventricular recovery in heart failure patients on mechanical circulatory support. Circulation, (122): 15965, 2010.

• Haberman SC, Habib PJ, Oyenuga O, Tanaka H, Adelstein E, Gorcsan J. Echocardiographic dyssynchrony by tissue doppler, speckle tracking and routine pulsed doppler are additive to predict survival following Cardiac Resynchronization Therapy. Circulation, (122): A12662, November 2010.

• Oyenuga O, Habib HJ, Haberman SC, Tanaka H, Adelstein E, Saba S, Gorcsan J. Echocardiographic yu index along with degree of QRS widening predicts survival following Cardiac Resynchronization. Circulation, (122): A13016, November 2010.

• Habib PJ, Oyenuga O, Haberman SC, Tanaka H, Adelstein E, Gorcsan J. QRS duration and radial dyssynchrony are associated with survival in patients with ischemic cardiomyopathy undergoing Cardiac Resynchronization Therapy. Circulation, (122): A12345, November 2010.

• Habib PJ, Oyenuga O, Haberman SC, Tanaka H, Adelstein E, Onishi T, Gorcsan J. The degree of baseline radial dyssynchrony predicts long-term survival following Cardiac Resynchronization Therapy. Circulation, (122): A12369, November 2010.

• Tanaka H, Oyenuga O, Habib P, Saba S, Gorcsan J. Association of short-term improvement in left ventricular torsion by Echocardiographic Speckle-Tracking with long-term outcome after Cardiac Resynchronization Therapy. J Am Soc of Echocardiolography, (23): B15, May 2010.

• Habib PJ, Oyenuga O, Tanaka H, Haberman SC, Adelstein E, Gorcsan J. Novel transverse speckle tracking dyssynchrony predicts response to Cardiac Resynchronization Therapy. J Am Society of Echocardiolography, (23): B16, May 2010.

• Oyenuga O, Habib P, Tanaka H, Adelstein E, Gorcsan J. Speckle tracking echocardiographic radial strain predicts survival in patients with narrower QRS duration following Cardiac Resynchronization. J Am Soc of Echocardiolography, (23): B15, May 2010.

• Tanaka H, Oyenuga O, Habib P, Saba S, Gorcsan J. Three-dimensional speckletracking radial strain predicts ejection fraction response to Cardiac Resynchronization Therapy. J Am Society of Echocardiolography, (23): B17, May 2010.

• Tanaka H, Oyenuga O, Habib P, Haberman SC, Saba S, Gorcsan J. Clinical and echocardiographic characteristics of heart failure patients with wide QRS but without mechanical dyssynchrony and their response to Resynchronization Therapy. J Am College of Cardiology, (55): A95.E897, March 2010.

• Habib P, Oyenuga O, Tanaka H, Haberman SC, Adelstein EC, Gorcsan J. Echocardiographic dyssynchrony predicts survival following Cardiac Resynchronization Therapy. J Am College of Cardiology, (55): A84.E793, March 2010.  

• Haberman SC, Adelstein EC, Tanaka H, Oyenuga O, Habib P, Gorcsan J. Gender similarities in survival following Cardiac Resynchronization Therapy despite differences in patient characteristics. J Am College of Cardiology, (55): A4.E35, March 2010.

• Tanaka H, Oyenuga O, Habib P, Adelstein EC, Gorcsan J. Multiplane speckle tracking imaging to quantify dyssynchrony and predict long-term outcome after Cardiac Resynchronization Therapy. J Am College of Cardiology, (55): A66.E621, March 2010.

• Oyenuga O, Habib P, Tanaka H, Haberman SC, Adelstein EC, Saba S, Gorcsan J. Survival benefit from Cardiac Resynchronization Therapy in patients with borderline QRS duration. J Am College of Cardiology, (55): A3.E26, March 2010.

• Tanaka H, Oyenuga O, Habib P, Saba S, Gorcsan J. Three-dimensional radial, circumferential and longitudinal speckle-tracking strain to quantify dyssynchrony. J Am College of Cardiology, (55): A78.E735, March 2010.

• Hara H, Tanaka H, Oyenuga O, Kim HN, Schwartzman D, Saba S, Gorcsan J. Differences in dyssynchrony and ejection fraction response to Cardiac Resynchronization Therapy in patients with and without left bundle branch block. J Am Society of Echocardiolography, (22): 577, May 2009.

• Hara H, Tanaka H, Oyenuga O, Kim HN, Schwartzman D, Saba S, Gorcsan J. Speckle tracking anteroseptal strain patterns predict response after Cardiac Resynchronization Therapy. J Am Society of Echocardiolography, (22): 581, May 2009.

• Hideyuki H, Hidekazu T, Oyenuga O, Han-Na K, Schwartzman D, Gorcsan J. Comparison of dyssynchrony and response to Resynchronization Therapy in patients with intrinsic left bundle branch block to those with chronic right ventricular pacing. J Am College of Cardiology, (53): A135, March 2009.

• Hideyuki H, Hidekazu T, Oyenuga O, Han-Na K, Schwartzman D, Gorcsan J. Improvements in repolarization following Cardiac Resynchronization Therapy are associated with ejection fraction response and improvements in mechanical dyssynchrony. J Am College of Cardiology, (53): A126, March 2009.

• Hideyuki H, Oyenuga O, Hidekazu T, Han-Na K, Saba S, Gorcsan J. Additive value of interventricular mechanical delay to intraventricular dyssynchrony for predicting response to Cardiac Resynchronization Therapy. Circulation, (118): S_870, October 2008.

• Han-Na K, Hideyuki H, Hidekazu T, Oyenuga O, Schwartzman D, Gorcsan J. Comparison of dyssynchrony in heart failure patients with narrow QRS to those with wide QRS: Implications for Resynchronization Therapy. Circulation, (118): S_869-S_870, October 2008.

• Hidekazu H, Hideyuki H, Oyenuga O, Han-Na K, Schwartzman D, Gorcsan J. Degree of left ventricular dyssynchrony in heart failure patients is related to QRS width. Circulation, (118): S_780, October 2008.

• Oyenuga O, Hideyuki H, Hidekazu T, Han-Na K, Saba S, Gorcsan J. Usefulness of echochardiographic measures of dyssynchrony in patients with borderline QRS duration for selection for Resynchronization Therapy. Circulation, (118): S_870, October 2008.

• Onishi T, Onishi T, Oyenuga O, Haberman SC, Saba S, Gorcsan J. Relationship of post-systolic shortening to long-term survival after Cardiac Resynchronization Therapy. Circulation, 2011. (In Press) 

​

Presentations/Exhibits/Productions

• Oyenuga O. Electrical problems with the pump. Adavances in Heart Failure Management, Texas Tech University Health Sciences Center, 2018. (Peer Reviewed) Oyenuga O. Case Presentation National Meeting, American College of Cardiology (ACC), 2017.

• Oyenuga O. Comparison of Simple Pulsed Doppler Measures of Global Dyssynchony to Predict Ejection Fraction Response to Cardiac Resynchronization Therapy., University of Pittsburgh Medical Center, McKeesport, Pennsylvania, May 2008. 

 

SCHEDULE APPOINTMENT WITH DR. AMIN:

• Mansfield Clinic
• South Arlington Clinic

BOARD CERTIFICATIONS:

• Clinical Cardiac Electrophysiology
• Cardiovascular Disease

HOSPITALS:

• Methodist Dallas Medical Center
• Methodist Mansfield Medical Center
• Texas Health Heart & Vascular Hospital Arlington
• Texas Health Huguley Hospital Fort Worth South
• USMD Hospital at Arlington

EDUCATION:

• Fellowship, Cardiac Electrophysiology: University of Utah, Salt Lake City, Utah
• Fellowship, Cardiovascular Disease: University of Florida, Jacksonville, Florida 
• Residency, Internal Medicine:  University of Texas Southwestern Medical Center, Dallas, Texas
• Internship, Internal Medicine:  University of Texas Southwestern Medical Center, Dallas, Texas
• Medical School, MD Degree: Texas A & M College of Medicine, College Station, Texas
• Undergraduate, B.S. Electrical Engineering (Summa Cum Laude): University of Texas at Arlington

PUBLICATIONS/MEDIA:

• World’s Smallest Pacemaker at Medical City Arlington - Nov 8, 2017

 

BOARD CERTIFICATIONS:

• Interventional Cardiology
• Cardiovascular Disease
• Nuclear Cardiology
• Echocardiography
• Internal Medicine

HOSPITALS:

• Baylor Scott & White Medical Center - Lake Pointe
• Baylor Scott & White Medical Center - Plano
• Baylor Scott & White | The Heart Hospital - Denton
• Baylor Scott & White | The Heart Hospital - Plano
• Methodist Richardson Medical Center

EDUCATION:

• Fellowship, Interventional Cardiology:  Saint Vincent’s Hospital and Medical Centers, NY
• Fellowship, Cardiovascular Disease:  Saint Vincent’s Hospital and Medical Centers, NY
• Residency, Internal Medicine: Albert Einstein College of Medicine/Montefiore Medical Center, NY
• Medical School, MD Degree:  SUNY Stonybrook School of Medicine, NY
• Undergraduate, BS Degree:  CUNY City College, NY

HONORS/AWARDS:

• Saint Vincent’s Hospital and Medical Centers, New York (2007-2008)
• Saint Vincent’s Hospital and Medical Centers, New York (2004-2007)
• Albert Einstein College of Medicine/Montefiore Medical Center, New York (2001-2004)
• SUNY Stonybrook School of Medicine, New York (1994-2001)
• CUNY City College, New York (1994-2001)

PROFESSIONAL APPOINTMENTS:

• Medical Executive Committee, Member - Baylor Scott and White Medical Center at Garland, Texas (2012-2018)
• American Heart Association/Fellows Society of Greater New York, Fellow Liaison – St. Vincent's Hospital, NY (2005-2006)

PROFESSIONAL ASSOCIATIONS:

• The Society of Cardiovascular Angiography and Interventions, SCAI-Member (2007-present)
• North American Society of Cardiovascular Imaging, NASCI-Member (2006-present)
• American Society of Echocardiography, ASE-Member (2004-present)
• American Society of Nuclear Cardiology, ASNC-Affiliate Member (2004-present)
• American College of Cardiology, ACC-Member (2004-present)
• American Heart Association, AHA-Member (2004-present)
• American Medical Association, AMA-Member (2001-present)

PUBLICATIONS:

Research:

• Co-Investigator, "Vascular Supply of the Anterobasal Segment of the Left Ventricle, Retrospective review of 45 consecutive coronary angiography cases looking at the Anterobasal Segment contractility along with patency of the native Left Anterior Descending Artery and Left Internal Mammary Artery." (2005-2006)
• Co-Investigator, Worked with Dr.Thierry LeJemtel on the Brain Natriuretic Peptide (BNP) study. The purpose of the project was to determine if BNP levels could be used to determine the cardiovascular status of patients with Congestive Heart Failure (2002)

​

Presentations:

• Presentation: Pre-Op Clearance to the Anesthesia department at St.Vincent's Hospital and Medical Center. (2006)
• Electrocardiogram Interpretation for medical students and house staff at St. Vincent's Hospital and Medical Center/New York Medical College. (2004-2006)
• Over 100 presentations through out fellowship in case management conferences, cardiac catheterization conferences, M & M and cardiac surgical conferences, Journal club conferences, Cardiac Critical Care conferences, EP, Echo, EKG, CHF and Nuclear conferences

 

BOARD CERTIFICATIONS:

• Advanced Heart Failure and Transplant Cardiology

HOSPITALS:

• Baylor Scott & White Heart and Vascular Hospital - Dallas
• Baylor Scott & White Institute for Rehabilitation
• Baylor Scott & White Heart | The Heart Hospital Plano
• Baylor University Medical Center
• Kindred Hospital Dallas

EDUCATION:

• Fellowship, Heart Failure/Transplant Cardiology: University of Texas Southwestern Medical Center 
• Fellowship, Cardiology: University of Texas Southwestern Medical Center
• Residency, Internal Medicine:  University of Texas Southwestern Medical Center 
• Internship, Internal Medicine:  University of Texas Southwestern Medical Center 
• Medical School, M.D. Degree: University of Texas Southwestern Medical Center 
• Undergraduate, B.S. in Biochemistry: University of Dallas, Irving, TX 

AWARDS/HONORS:

• D-Magazine's BEST DOCTORS: 2013 - 2022
• Texas Monthly's Super Doctors (Hall of Fame): 2010 - 2022

PROFESSIONAL APPOINTMENTS:

• Chief, Transplant Cardiology, Congestive Heart Failure and Mechanical Circulatory Support, BUMC (January 2015 - current)
• Clinical Associate Professor, Texas A&M Health Science Center College of Medicine (March 2012 - current)
• Medical Director, Cardiac Transplantation, BUMC (2003-2014)

PROFESSIONAL AFFILIATIONS:

• Member and Founder, Women in Transplant and MCS
  • 2021 - Present, President
• Member and Fellow, American College of Cardiology
  • 2017 - 2019, Chair Heart Failure Division for TX ACC Chapter
  • 2018 - 2021, Secretary/Treasurer for TX ACC Chapter
  • 2021 - 2022, President-Elect TX ACC, Governor-Elect for TX, ACC
  • 2022 - Present, President TX ACC, Governor for TX Chapter, ACC
  • 2022 - Present, Member, National HF and Transplant Council, ACC
• Member, American Heart Association
• Member, Texas Medical Association
  • 2014 - 2017, Council on Transplantation and Transfusion
• Member, Dallas County Medical Society
• Member, Society for Cardiovascular Angiography and Interventions (SCAI)
  • 2017 – 2018, Member, Writing Group, SCAI/AHA Clinical Expert Consensus Document on the Invasive Cardiologist
  • 2018 – 2019, Member, Writing Group, SCAI/HFSA Clinical Expert Consensus Document on Defining the Spectrum of Cardiogenic Shock
  • 2021 – 2022, Member, Writing Group, SCAI Update Document on Shock
• Member and Fellow, Heart Failure Society of America (HFSA)
• Member, International Society of Heart and Lung Transplantation (ISHLT)
  • 2017 - 2018, Chair of Heart Failure/Transplant Academy
  • 2017 - 2022, Co-Chair, Donor Management and Allocation Consensus Document
  • 2022 - Present, Member, Cardiogenic Shock Group
• Member and Fellow, American Society for Transplant Physicians
  • 2017 - 2019, Committee Member-at-Large, Thoracic and Critical Care Community of Practice
  • 2018 - 2019, Co-Chair of Thoracic and Critical Care COP
  • 2019 - 2022, Chair of Thoracic and Critical Care COP
• Member, Baylor Scott and White Health, Heart Failure Initiative
• Member, Baylor Scott and White Health, Cardiovascular Governance
• Chair, Baylor Scott and White Health, Cardiogenic Shock Initiative
• Member, UNOS, Thoracic Committee, July 2012-June 2014, July 2017-June 2020
  • 2005 - Present, Baylor University Medical Center Representative, Region 4 UNOS Committee
  • 2012 - 2014, 2017 - 2020, Director, Region 4 UNOS
  • 2012 - 2014, 2017 - 2020, Region 4 Representative, UNOS National Committee
  • 2017 – 2018, Chair, Heart Allocation Committee
  • 2017 - 2020, Chair, Cardiac Sub-Committee
  • 2020 - 2022, Chair, Cardiac Committee
  • 2018 - 2019, Member, OPTN/UNOS Ad Hoc Systems Performance Committee
  • 2021 - Present, Member, OPTN Ad Hoc Multi-Organ Transplantation Committee
• Member, Texas Transplantation Society
  • 2014 - 2017, Heart Transplantation Councilor
• Heart Failure Rotation for Cardiology Fellowship
  • 2012 - Present, Director
• Advisory Boards – Abiomed, Evaheart, Abbott, Natera, CareDx
• Associate Editor, American Journal of Cardiology (2017- present)

PUBLICATIONS/MEDIA:

Peer Reviewed Scientific Papers

• Manhal Izzy, Brett E. Fortune, Marina Serper, Nicole Bhave, Andrew deLemos, Juan F. Gallegos-Orozco, Cesar Guerrero-Miranda, Shelley Hall, Matthew E. Harinstein, Maria G. Karas, Michael Kriss, Nicholas Lim, Maryse Palardy, Deirdre Sawinski, Emily Schonfeld, Anil Seetharam, Pratima Sharma, Jose Tallaj, Darshana M. Dadhania, and Lisa B. VanWagner. Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisplinary practice-based recommendations.  Am J Transplant 2022 December;22(12):2740-2758.  PMID: 35359027.
• Mehra MR, Nayak A, Morris AA, Lanfear DE, Nemeh H, Desai S, Bansal A, Guerrero-Miranda C, Hall S, Cleveland JC Jr, Goldstein DJ, Uriel N, Chen L, Bailey S, Anyanwu A, Heatley G, Chuang J, Estep JD. Prediction of survival after implantation of a fully magnetically levitated left ventricular assist device.  JACC Heart Fail 2022 December;10(12):948-959.  PMID: 36456068. 
• Hernandez-Montfort J, Kanwar M, Sinha SS, Garan AR, Blumer V, Kataria R, Whitehead EH, Yin M, Li B, Zhang Y, Thayer KL, Baca P, Dieng F, Harwani NM, Guglin M, Abraham J, Hickey G, Nathan S, Wencker D, Hall S, Schwartzman A, Khalife W, Li S, Mahr C, Kim J, Vorovich E, Pahuja M, Burkhoff D, Kapur NK. Clinical presentation and in-hospital trajectory of heart failure and cardiogenic shock.  JACC Heart Fail 2022 October 31:S2213-1779(22)00590.  PMID: 36342421. (epub ahead of print). 
• Copeland H, Knezevic I, Baran DA, Rao V, Pham M, Gustafsson F, Pinney S, Lima B, Masetti M, Ciarka A, Rajagopalan N, Torres A, Hsich E, Patel JK, Goldraich LA, Colvin M, Segovia J, Ross H, Ginwalla M, Sharif-Kashani B, Farr MA, Potena L, Kobashigawa J, Crespo-Leiro MG, Altman N, Wagner F, Cook J, Stosor V, Grossi PA, Khush K, Yagdi T, Restaino S, Tsui S, Absi D, Sokos G, Zuckermann A, Wayda B, Felius J, Hall SA. Donor heart selection: Evidence-based guidelines for providers.  J Heart Lung Transplant 2022 September 20:S1053-2498(22)02113-1.  PMID: 36357275. (epub ahead of print). 
• Mahmoud Salem, Farah Al-Saffar, and Shelley Hall. Management of pulmonary hypertension in patients on left ventricular assist device support. Rev Cardiovasc Med 2022 September 22;23(9):308-317. https://doi.org/10.31083/j.rcm2309308
• Mandeep R Mehra, MD, MSc, Daniel J. Goldstein, MD, Joseph C Cleveland, MD, Jenifer A Cowger, Md, MS, Shelly Hall, MD, Christopher T Salerno, MD, Yoshifumi Naka, MD, PhD, Douglas Horstmanshof, MD, Joyce Chuang, PhD, AiJia Wang, MPH, and Nir Uriel, MD, MSc. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial.  JAMA 2022 September 8. (epub ahead of print). doi:10.1001/jama.2002.16197
• Aayla K, Jamil, Kristen M. Tecson, Tatyana T. Ganz, Shane Blankenship, Joost Felius, Sandra A. Carey, and Shelley A. Hall. Heart transplant recipients’ perspectives on invasive versus non-invasive graft failure surveillance methods.  J Heart Lung Transplant 2022 August. (epub ahead of print – anticipated print 2023 January 1;57:41-44).
• Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Gracia-Tsao G, Hall, SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension.  Clin Gastroenterol Hepatol 2022 Aug;20(8):1636-1662. (epub 2021 Jul 15:S1542-3565(21)00749-7) PMID: 34274511.
• Justin R. Boike, Bartley G. Thornburg, Sumeet K. Asrani, Michael B. Fallon, Brett E. Fortune, Manhal J. Izzy, Elizabeth C. Verna, Juan G. Abraldes, Andrew S. Allegretti, Jasmohan S. Bajaj, Scott W. Biggins,Michael D. Darcy, Maryjane A. Farr, Khashayar Farsad,Guadalupe Garcia-Tsao, Shelley A. Hall, Caroline C. Jadlowiec,Michael J. Krowka, Jeanne Laberge, Edward W. Lee,David C. Mulligan, Mitra K. Nadim, Patrick G. Northup, Riad Salem,Joseph J. Shatzel, Cathryn J. Shaw, Douglas A. Simonetto,Jonathan Susman, Pallav Kolli, and Lisa B. VanWagner onbehalf of the Advancing Liver Therapeutic Approaches (ALTA) Consortium. Narrative Review.  North American practice-based recommendations for transjugular intrahepatic portosymstemic shunts in portal hypertension.  Clinical Gastroenterology and Hepatology 2022;20:1636-1662
• Alam A, Jamil AK, Van Zyl JS, Medel-Martinez H, Bottiglieri T, Wasek B, Felius J, Lima B, Hall SA, and Joseph SM. Urinary cell-cycle arrest biomarkers as early predictors of acute kidney injury after ventricular assist device implantation or cardiac transplantation.  J Cardiothorac Vasc Anesth 2022 August;36(8 Pt A):2303-2312.  PMID: 34774406. Epub 2021 Oct 16.
• Ebong IA, DeFilippis EM, Hamad EA, Hsich EM, Randhawa VK, Billia F, Kassi M, Bhardwaj A, Byku M, Munagala MR, Rao RA, Hackmann AE, Gidea CG, DeMarco T, and Hall SA. Special considerations in the care of women with advanced heart failure.  Front Cardiovasc Med 2022 July 11;9:890108 (ecollection 2022).  PMID: 35898277
• Kapur NK, Kanwar M, Snha SS, Thayer KL, Garan AR, Hernandez-Montfort J, Zhang Y, Li B, Baca P, Dieng F, Harwani NM, Abraham J, Hickey G, Nathan S, Wencker D, Hall S, Schwartzman A, Khalife W, Li S, Mahr C, Kim JH, Vorovich E, Whitehead EH, Blumer V, and Burkhoff D. Criteria for defining stages of cardiogenic shock severity.  J Am Coll Cardiol 2022 July 19;80(3):185-198.  doi: 10.1016/j.jacc.2022.04.049. PMID: 
• Salerno CT, Hayward C, Hall S, Goldstein D, Saeed D, Schmitto J, Kaczorowski D, Molina E, Zimpfer D, Tsui S, Soltesz E, Pham DT, Mokadam NA, Kilic A, Davis E, Feller E, Lorts A, Silvestry S, Slaughter MS, Potapov E, Atluri P, Cowger J, Pagani FD; HeartWare HVAD System to HeartMate 3 Left Ventricular Assist System Device Exchange Advisory Group. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg 2022 June;163(6):2120-2127. PMID 35341579.  (epub 2022 March 24).
• Bhardwaj A, Ramu B, Blumer V, Cogswell, R, Demarco T, Hall S; Executive Committee of the Women in Heart Transplantation and Mechanical Circulatory Support Network. J Card Fail 2022 June;28(6):1031-1034.  PMID: 35470054.
• Bhardwaj A, Ramu B, Blumer V, Cogswell R, Demarco T, Hall S; Executive Committee of the Women in Heart Transplantation and Mechanical Circulatory Support Network. Women empowering women in heart transplantation and mechanical circulatory support. J Card Fail 2022 June;28(6):1031-1034.  PMID 35470054. (epub 2022 April 22).
• Kobashigawa JA, Hall S, Farr M, Blumberg E, Michael Borkon A, Colvin M, Copeland H, Eisen H, Johnson M, Jorde U, Khush K, Kirklin JK, Patel J, Pinney S, Saadaeijahromi H, Schold JD, Stehlik J; Consensus Conference Participants. Proceedings from the metrics forum in heart transplantation for performance monitoring.  Am J Transplant 2022 May;22(5):1299-1306.  PMID 34866328.
• Amit Alam, Johanna van Zyl, Gregory Milligan, Staci McKean, Raksha Patel, and Shelley Hall. Evolving the surveillance and workup of heart transplant rejection: A real-world analysis of the molecular microscope diagnostic system.  Am J Transplant 2022 May. (epub ahead of print). https://doi.org/10.1111/ajt.17087
• Patel NH, Guerrero-Miranda C, Hall S, Rafael AE, Brown WM, and Bindra AS. Fusion of bovine tissue aortic valve leaflets in a patient with left ventricular assist device.  JACC Case Report. 2022 May 18;4(10):604-609.  PMID: 35615220
• Aasim Afzal, MD, Johanna van Zyl, PhD, Tariq Nisar, MPH, Aaron Y. Kluger, MPH, Aayla K. Jamil, MPH, Joost Felius, PhD, Shelley A. Hall, MD, and Parag Kale, MD. Trends in hospital admissions for systolic and diastolic heart failure in the United States between 2004 and 2017.  Am J Card 2022 May 15;171:99-104.
• Jon A. Kobashigawa, Shelley Hall, MaryJane Farr, Emily Blumberg, A. Michael Borkon, Monica Colvin, Hannah Copeland, Howard Eisen, Maryl Johnson, Ulrich Jorde, Kiran Khush,J ames K. Kirklin,J ignesh Patel, Sean Pinney, Hannaneh Saadaeijahromi, Jesse D. Schold, and Josef Stehlik, the Consensus Conference. Meeting Report. Proceedings from the metrics forum in heart transplantation for performance monitoring.  Am J Transplant 2022 May;22(5):1299-1306. https://doi.org/10.1111/ajt.16901
• Shelley A. Hall, Hannah Copeland, Amit Alam, and Susan M. Joseph. The “right” definition for post-left ventricular assist device right heart failure: The more we learn, the less we know.  Front Cardiovasc Med 2022 April 26. https://doi.org/10.3389/fcvm.2022.893327
• John R, Kanwar MK, Cleveland JC Jr, Uriel N, Naka Y, Salerno C, Horstmanshof D, Hall SA, Cowger JA, Heatley G, Somo SI, and Mehra MR. J Thorac Cardiovasc Surg 2022 April 25;S0022-5223(22)00498-6.  (epub ahead of print).  PMID: 35643769.
• Amit Alam, Donna Mancini, and Shelley Hall. Should withdrawal of care be listed as a cause of death.  Ann Thorac Surg 2022 April;113(4):1393-1304. PMID: 33753056.
• Salerno CT, Hayward C, Hall S, Goldstein D, Saeed D, Schmitto J, Kaczorowski D, Molina E, Zimpfer D, Tsui S, Soltesz E, Pham DT, Mokadam NA, Kilic A, Davis E, Feller E, Lorts A, Silvestry S, Slaughter MS, Potapov E, Atluri P, Cowger J, Pagani FD; HeartWare HVAD System to HeartMate 3 Left Ventricular Assist System Device Exchange Advisory Group. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg 2022 March 15:S0022-5223(21)01738-4 (epub ahead of print) doi: 10.1016/j.jtcvs.2021.11.085.
• Salerno CT, Hayward C, Hall S, Goldstein D, Saeed D, Schmitto J, Kaczorowski D, Molina E, Zimpfer D, Tsui S, Soltesz E, Pham DT, Mokadam NA, Kilic A, Davis E, Feller E, Lorts A, Silvestry S, Slaughter MS, Potapov E, Atluri P, Cowger J, Pagani FD; HeartWare HVAD System to HeartMate 3 Left Ventricular Assist System Device Exchange Advisory Group. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Thorac Cardiovasc Surg 2022 March 24 (epub ahead of print). doi: 10.1093/ejcts/ezac169.
• Michael R. Zile, Akshay S. Desai, Maria Rosa Costanzo, Anique Ducharme, Alan Maisel, Mandeep R. Mehra, Sara Paul, Samuel F. Sears, Frank Smart, Christopher Chien, Ashrith Guha, Jason L. Guichard, Shelley Hall, Orvar Jonsson, Nessa Johnson, Poornima Sood, John Henderson, Philip B. Adamson, and JoAnn Lindenfeld. The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic.  Eur Heart J 2022 March 10;00:1-16.  (epub ahead of print) https://doi.org/10.1093/eurheartj/ehac114
• Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 2022 March 8;79(9):933-946.
• Afzal A, Alam A, van Zyl JS, Felius J, Hall S, and Carey SA. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.  Clin Transplant 2022 March;36(3):e14549.
• Cowger JA, Estep JD, Rinde-Hoffman DA, Givertz MM, Anderson AS, Jacoby D, Chen L, Brieke A, Mahr C, Hall S, Ewald GA, Dirckx N, Baker AT, and Pinney SP. Variability in blood pressure assessment in patients supported with the HeartMate 3TM.  ASAIO J 2022 March 1;68(3):374-383.
• Patlolla SS, Gong T, and Hall S. Balancing the tug of war: intraoperative and postoperative management of multiorgan transplantation.  Curr Opin Organ Transplant 2022 Feb 1;27(1):57-63.  doi: 10.1097/MOT.0000000000000939
• Baran DA, Hall S, and Cowger J. Reply: Humanizing policies and allocation systems: a need to refocus on patient-centered care.  JACC Heart Fail 2022 Feb;10(2):145.
• Sovic W, Mathew C, Blough B, Monday K-A, Sam T, Zafar H, Guerrero-Miranda C, Sherwood M, Hebert C, Hall S, Alam A. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting. Methodist DeBakey Cardiovasc J. 2021;17(3):28-31. doi: 10.14797/mdcvj.576
• David A. Baran, MD, Shelley Hall, MD, and Jennifer Cowger, MD. Letter to the Editor: Everything I Wanted. JACC 2021 November;9(11):858-859.   https://doi.org/10.1016/j.jchf.2021.04.017
• Alam A, Van Zyl, Nayyar N, Hall S, and Jermyn R. Improvement in metabolic co-morbidities after implantation of CardioMEMS in patients with heart failure with preserved ejection fraction phenotype.  J Clin Med 2021 September 22;10(19):4308.  PMID: 34640323
• Van Zyl JS, Sam T, Clark DM, Felius J, Doss AK, Kerlee KR, Cheung ZO, Martits-Chalangari K, Jamil AK, Carey SA, Gottlieb RL, Guerrero-Miranda CY, Kale P, and Hall SA. De novo tacrolimus extended-release tablets (LCPT) versus twice-daily tacrolimus in adult heart transplantation: Results of a single-center non-inferiority matched control trial.  Clin Transplant 2021 September 16:e14487 (epub ahead of print). PMID: 34529289
• Van Zyl, JS., Felius, J., Alam, A., Hall, SA., Jamil, AK, Spak, CW, and Gottlieb, RL. Dynamic albumin values as clinical surrogate for COVID-19 therapeutics.  J Investig Med 2021 Aug;69(6):1260. PMID: 34050000
• Alam A, Van Zyl JS, Hall SA, and Sam T. Impact of risk-stratified mycophenolate dosing in heart transplantation. Clin Transplant 2021 Jul 27 (epub ahead of print).
• Alam A., Wilcox JE, and Hall SA. The traditional endomyocardial biopsy: Opportunities to rethink its role as the gold standard.  J Card Fail 2021 Jul 4:S1071-9164(21)00262-1.
• Squiers JJ, DiMaio JM, Van Zyl J, Lima B, Gonzalez-Stawinski G, Rafael AE, Meyer DM, and Hall SA. Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation.  Eur J Cardiothorac Surg 2021 Jun 7. (epub ahead of print).
• Mehra MR, Cleveland JC Jr, Uriel N, Cowger JA, Hall S, Horstmanshof D, Naka Y, Salerno CT, Chuang J, Williams C, Goldstein DJ, MOMENTUM 3 Investigators. Primary results of long-term outcomes in the MOMENTUM 3 Pivotal Trial and continued access protocol study phase: A study of  2200 HeartMate 3 left ventricular assist device implants.  Eur J Heart Fail 2021 May 1 https://pubmed.ncbi.nlm.nih.gov/33932272/ (epub ahead of print).
• Alam A., Carey SA, and Hall SA. Polypill in persons without cardiovascular disease. (Comment) N Engl J Med 2021 April 29:384(17):1674. https://www.nejm.org/doi/10.1056/NEJMc2102972
• van Zyl JS, Alam A, Felius J, Youssef RM, Bhakta D, Jack C, Jamil AK, Hall, SA, Klintmalm GB, Spak CW, and Gottlieb RL. ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease.  J Investig Med 2021 March;69(3):710-718. https://pubmed.ncbi.nlm.nih.gov/33431604/ [epub ahead of print 2021 Jan 11].
• Song L, Guerrero-Miranda C, Hall S, Mahr C. Utility of Hemodynamic Profiling Using Pulmonary Artery Catheters in Cardiogenic Shock. 2021 April 2 (epub ahead of print).
• Amit Alam, MD, Christo Mathew, MD, Elle Dib, MD, Aayla Jamil, MBBs, Cesar Y. Guerrero-Miranda, MD, Brian, Lima, MD, Dan Meyer, MD, Aldo Rafael, MD, Shelley A. Hall, MD, and Susan Joseph, MD. Unexpected twists: A 61-year-old male with repeated HeartMate II complications and subsequent replacement with HeartMate III.  Methodist DeBakey Cardiovasc J 2021 March;17(1):69-71.
• Alam A., Kobashigawa J, Milligan GP, and Hall SA. Evolution of testing for Allograft rejection after orthotopic heart transplantation without the evolution of guidelines and a proposal for the multidisciplinary health-team approach.  Am J Cardiol 2021 June 15:149:147-149.
• Alam A., Mancini D, and Hall S. Should withdrawal of care be listed as a case of death?  Ann Thorac Surg 2021 March 19:S0003-4975(21)00534-8 (epub ahead of print).
• Jamil AK, Afzal A, Nisar T, Kluger AY, Felius J, Wencker D, Hall SA, and Kale P. Trends in post-heart transplant biopsies for graft rejection versus nonrejection.  Proc (Bayl Univ Med Cent) 2021 Jan 26:34(3):345-348.  https://pubmed.ncbi.nlm.nih.gov/33953467/
• Katelyn D. Brown, MS, Jenny Adams, PhD, Dan M. Meyer, MD, Robert L. Gottlieb, MD, PhD, and Shelley A. Hall, MD. The utility of boxing for cardiac prehabilitation.  Proc – Bayl Univ Med Cent 2021;34(1):182-184.
• Manreet K. Kanwar, MD, Kiran K. Khush, MD, Sean Pinney, MD, Claire Sherman, PhD, James Fleming, PharmD, Shelley Hall, MD, Jeffrey Teuteberg, MD, Nir Uriel, MD, and Jon Kobashigawa, MD. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.  J Heart Lung Transplant 2021 Feb;40(2):101-107.  https://pubmed.ncbi.nlm.nih.gov/33341360/  [epub 2020 November 22].
• Sandau KE, Lee, CS, Faulkner, KM, Pozehl, B, Eckman P, Garberich R, Weaver CE, Joseph SM, Hall S, Carey SA, Chaudhry SP, Schroeder SE, Hoffman RO III, Feldman D, Birati EY, Soni M, Marble J, Jurgens CT, Hoglund BA, Cowger JA.  Health-related quality of life with a left ventricular assist device (QOLVAD) questionnaire: Development and psychometrics of a new instrument. [accepted for publication] J Cardiovasc Nurse. 2021 March-April 01;36(2):172-184. https://pubmed.ncbi.nlm.nih.gov/33306621/
• Ahmed Seliem and Shelley A Hall. The new era of cardiogenic shock: Progress in mechanical circulatory support.  Curr Heart Fail Rep 2020 December;17(6):325-332. [epub ahead of print 2020 Sept 16]. PMID: 32936410
• Amit Alam, MD, Dan M. Meyer, MD, and Shelley A. Hall, MD. Commentary: History is prologue: if we fail to learn from our past we are doomed to repeat it. Editorial.  J Thorac Cardiovasc Surg 2021 May;161(5):1847-1848. https:// https://doi.org/10.1016/j.jtcvs.2020.08.099 [epub 3 Sept 2020].
• Tim Gong and Shelley Hall. Considerations and experience driving expansion of combined heart-liver transplantation.  Curr Opin Organ Transplant 2020 October ;25(5):496-500. [epub ahead of print 2020 Aug 10]. https://pubmed.ncbi.nlm.nih.gov/32796180/
• Cesar Y Guerrero-Miranda and Shelley A Hall. Editorial.  Rethinking the future with evolving technology: It’s time to empower change in heart transplantation.  Am J Transplant 2021 Feb;21(2):453-455. https://doi.org/10.1111/ajt.16221 [epub 2020 Aug 23].
• Jon Kobashigawa, Palak Shah, Susan Joseph, Micheal Olymbios, Geetha Bhat, Kumud Dhital, Howard Eisen, Evan Kransdorf, Jignesh Patel, Rafael Skorka, Sean Pinney, Michael E Wilson, Shelley Hall, Heart Frailty Workgroup. Frailty in heart transplantation: Report from the heart workgroup of a consensus conference on frailty.  Am J Transplant 2021 Feb;21(2):636-644.  https://pubmed.ncbi.nlm.nih.gov/32659872/ [epub 2020 Aug 29].
• Hall, S. Multiorgan transplantation. In: Kittleson MM, Drazner MH, eds. Heart Failure Self-Assessment Program (HFSAP). American College of Cardiology, Washington, DC. acc.org/hfsap. Accessed 2020 June 15.
• Albert Hicks III, Jorge F Velazco, Salman Gohar, Ahmed Seliem, Shelley A Hall, and Jeffrey B Michel. Advanced heart failure with reduced ejection fraction.  Baylor University Medical Center Proc 2020 June 2:33(3);350-356.   https://pubmed.ncbi.nlm.nih.gov/32675952/
• Rebecca R. Goff, Kimberly Uccellini, Kelsi Lindblad, Shelley Hall, Ryan Davies, Maryjane Farr, Scott Silvestry, and Joseph G. Rogers. A change of heart: Preliminary results of the US 2018 adult heart allocation revision.  Am J Transplant 2020 October;20(10):2781-2790.  [epub ahead of print 2020 May 14]. https://pubmed.ncbi.nlm.nih.gov/32406597/
• Saima Aslam, Paolo Gross, Kelley H. Schlendorf, Are M. Holm, Ann E. Woolley, Emily Blumberg, Mandeep R. Mehra, working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant 2020 May 19:39(5):418-432. https://pubmed.ncbi.nlm.nih.gov/32362393/
• Cesar Y. Guerrero-Miranda, MD and Shelley A. Hall, MD. Cardiogenic shock in patients with advanced chronic heart failure.    Methodist Debakey Cardiovasc J 2020;16(1):22-26. https://pubmed.ncbi.nlm.nih.gov/32280414/
• Davies RR, Goff RR, Lease ED, Daly RC, and Hall S. Commentary in reply to Cogswell et al.: An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.  J Heart Lung Transplant 2020 January 30;S1053-2498(20):31358-9. https://pubmed.ncbi.nlm.nih.gov/32035726/
• Kiran K. Khush, Jignesh Patel, Sean Pinney, Andrew Kao, Rami Alharethi, Eugene DePasquale, Gregory Ewald, Peter Bernman, Manreet Kanwar, David Hiller, James P. Yee, Robert N. Woodward, Shelley Hall, and Jon Kobashigawa. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.  Am J Transplant 2019;19:2889-2899 [epub ahead of print 5 March 2019 ].
• Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D Jr, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Jiang SIB, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transplant Int 2019 Dec;32(12):1268-1276. [epub 2019 Oct 8].
• Moayedi Y, Fan CS, Miller RJH, Tremblay-Gravel M, Posada JGD, Manlhiot C, Hiller D, Yee J, Woodward R, McCaughan JA, Shullo MA, Hall SA, Pinney S, Khush KK, Ross HJ, Teuteberg JJ. Gene expression profiling and racial disparities in outcomes after heart transplantation. J Heart Lung Transplant 2019 Aug;38(8):820-829. [epub 2019 May 24].
• Harmon DM, Tecson KM, Jamil AK, Felius J, Gonzalez-Stawinski GV, Joseph SM, Hall SA. Outcomes of orthotopic heart transplantation and left ventricular assist device in patients aged 65 years or more with end-stage heart failure. Proc (Baylor Univ Medical Center). 2019 March 28;32(2):177-180.
• Baxter RD, Tecson KM, Still S, Collier JDG, Felius J, Joseph SM, Hall SA, and Lima B. Predictors and impact of right heart failure severity following left ventricular assist device implantation.  Jnl of Thoracic Disease 2019;11(Suppl. 6):S864-S70.
• Thakkar SJ, Grayburn PA, Hall SA, and Roberts WC. Orthotopic heart transplantation for ankylosing spondylitis masquerading as nonischemic cardiomyopathy.  Am J Cardiol 2019 May 15;123(10):1732-1735.
• Mehra, MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Asronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ; MOMENTUS 3 Investigators. A fully magnetically levitated left ventricular assist device – Final Report.  N Engl J Med 2019 April 25;380(17):1618-1627.
• Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E. Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Report from the American Society of Transplantation on frailty in solid organ transplantation.  Am J Transplant 2019 April;19(4):984-994. 

 

• Afzal A, Tecson KM, Jamil AK, Felius J, Garcha PS, Hall SA, Carey SA. The effect of obstructive sleep apnea on 3-year outcomes in patients who underwent orthotopic heart transplantation.  Am J Cardiol 2019 April 10.[epubl ahead of print]
• Roberts WC, Grayburn PA, Lander SR, Meyer DM, and Hall SA. Effect of progressive left ventricular dilatation on degree of mitral regurgitation secondary to mitral valve prolapse.  Am J Cardiol 2019 March 13. [epubl ahead of print]
• Roberts WC, Jameson LC, Bahmani A, Roberts CS, Rafael AE, and Hall SA. Morphological and functional characteristics of the right ventricle functioning as a systemic ventricle for decades after an atrial switch procedure for complete transposition of the great arteries.  Am J Cardiol 2019 March 13. [epubl ahead of print]
• Lee AY, Tecson KM, Lima B, Shaikh AF, Collier J, Still S, Baxter R, DiMaio JM, Felius J, Carey SA, Gonzalez-Stawinski GV, Nauret R, Wong M, Hall SA, Joseph SM. Durable Left ventricular assist device implantation in extremely obese heart failure patients. Artif Organs. 2019 Mar;43(3)234-241 and 2018 Oct 25. [Epub ahead of print] PubMed PMID: 30357882
• Samreen Fathima MD, Shelley A. Hall MD, Paul A. Grayburn MD, and William C. Roberts MD. The mitral valve 16 months after operative insertion of the Alfieri Stitch.  Am J Cardiol 2019;123:695-696.
• Tecson KM, Bass K, Felius J, Hall SA, Jamil AK, and Carey SA. Patient “activation” of patients referred for advanced heart failure therapy.  Am J Cardiol 2019 Feb 15;123(4):627-631.
• David M Harmon, Kristen M Tecson, Brian Lima, Justin D G Collier, Asad F Shaikh, Sasha Still, Ronald D Baxter, Nicole Lew, Richa Thakur, Joost Felius, Shelley A Hall, Gonzalo V Gonzalez-Stawinski, and Susan M Joseph. Outcomes of moderate-to-severe acute kidney injury following left ventricular assist device implantation.  Cardiorenal Medicine 2019 January 23;9(2):100-107.
• William C Roberts, Sarah Haque, and Shelley A Hall. Total 12-lead QRS voltage in patients having orthotopic heart transplantation for heart failure caused by Adriamycin-induced cardiomyopathy. Cardiology 2019;141(3):172-175.
• Guerrero-Miranda, CY and Hall, SA. Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support.  Ann Cardiothorac Surg 2019 Jan;8(1):123-128.
• Fayez S. Raza, MD, Andy Y. Lee, MD, Aayla K. Jamil, MPH, Huanying Qin, MS, Joost Felius, PhD, Aldo E. Rafael, MD, Gonzalo V. Gonzalez-Stawinski, MD, Shelley A. Hall, MD, Susan M. Joseph, MD, Brian Lima, MD and Amarinder S. Bindra, MD. Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation.  Am J Cardiol 2018;122:1902-1908.
• Suresh R Mulukutla, Joseph D Babb, David A Baran, Konstantinos Dean Boudoulas, Dmitriy N Feldman, Shelley A Hall, Henry S Jennings, Navin K Kapur, Sunil V Rao, Joel Reginelli, Jeffrey M Schussler, Eric H Yang, and Joaquin E Cigarroa. A quality framework for the role of invasive, non-interventional cardiologists in the present-day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement.  Catheterization And Cardiovascular Interventions. 2018.
• Thakkar R, Afzal A, Carey SA, Bass K, Felius J, Roberts WC, and Hall SA. Repeat cardiac transplant indicated by severe cardiac allograft vasculopathy in a patient with Danon Disease.  Rev Cardiovasc Med 2018 June;19(2):69-71.
• Roberts WC, Grayburn PA, Hall SA. Complications of radiofrequency ablation for supraventricular tachycardia in the wolff-parkinson-white syndrome associated with noncompaction cardiomyopathy. Am J Cardiol 2018 Jun 1;121(11):1442-1444.
• Tecson KM, Lima B, Lee AY, Raza FS, Ching G, Lee CH, Felius J, Baxter RD, Still S, Collier JDG, Hall SA, Joseph SM. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2018 May 17;7(11).
• Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, Moller JE, Schäfer A, Dixon SR, Hall S, Ohman EM, Mindrescu C, Moses J, O'Neill W. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.  Am Heart J 2018 May;199:115-121.
• Guerrero-Miranda CY, Hall SA. Editorial: Dog model holds promise for early mechanical unloading in patients with acute myocardial infarction. Circ Heart Fail 2018 May;11(5).
• Felius J, Hall SA. Employment status at the time of heart transplant listing.  J Heart Lung Transplant 2018 May;37(5):575-576.
• Gottlieb, Robert and Hall, Shelley. The new direct antiviral agents and hepatitis C in thoracic transplantation: Impact on donors and recipients.  Curr Transplant Rep 2018;5(2):145-152. Epub 2018 Apr 10.
• Sasha Still, Asad F. Shaikh, Huanying Qin, Joost Felius, Aayla K. Jamil, Giovanna Saracino, Themistokles Chamogeorgakis, Aldo E. Rafael, Juan C. MacHannaford, Susan M. Joseph, Shelley A. Hall, Gonzalo V. Gonzalez-Stawinski, and Brian Lima. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation.  Interactive Cardiovascular and Thoracic Surgery
• Sandra A. Carey and Shelley A. Hall. Gene Expression Profiling Scores in Dual Organ Transplant Patients Are Similar to Those in Heart-Only Recipients. Transplant Immunology 2018 (pending publication).
• Carey SA, Tecson KM, Bass K, Felius J, Hall SA. Patient activation with respect to advanced heart failure therapy in patients over age 65 years.  Heart Lung 2018 Apr 20.
• Timothy A. Gong and Shelley A. Hall. Targeting other modifiable risk factors for the prevention of heart failure: diabetes, smoking, obesity, and inactivity.  Current Cardiovascular Risk Reports 2018 April;12(4):Article 12:12.
• Gong, TA, Joseph SM, Lima B, Gonzalez-Stawinski GV, Jamil AK, Felius J, Qin H, Saracino G, Rafael AE, Kale P, Hall SA. Donor predicted heart mass as predictor of primary graft dysfunction.  J Heart Lung Transplant. 2018 Mar 17.
• Van Wagner LB, Harinstein ME, Runo JR, Darling C, Serper M, Hall S, Kobashigawa JA, and Hammell LL. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.  Am J Transplant 2018;18(1):30-42.
• Kristen M. Tecson, Anupama Vasudevan, Amarinder Bindra, Susan M. Joseph, Joost Felius, Shelley Hall, and Parag Kale.  Validation of peripherally inserted central cathether-derived fick cardiac outputs in patients with heart failure.  Am J Cardiol 2018;121(1):50-54.
• William Roberts, Tiffany Becker, Shelley Hall. Usefulness of total 12-lead qrs voltage as a clue to diagnosis of patients with cardiac sarcoidosis severe enough to warrant orthotopic heart transplant.  JAMA 2017 November 15.
• Kopecky, K. Afzal, A., Felius, J., Hall, SA, Mendez, JC, Assar, M., Mason, DP, and Bindra, AS. Bilateral sympathectomy for treatment of refractory ventricular tachycardia.  Pacing Clin Electrophysiol. 2018;41(1):93-5.
• Squierrs, JJ, DiMaio JM, Saracino G, Qin H, Felius J, Chamogeorgakis T, MacHannaford JC, Rafael AE, Kale, P, Joseph SM, Hall SA, Gonzalez-Stawinski GV, and Lima B. Utilization of high donor sequence number grafts in cardiac transplantation. Clinical Transplantation. 2018;32(1):e13128.
• Hall SA, Uriel N, Carey SA, Edens M, Gong G, Esposito M, O’Kelly R, Annamalai S, Aghili N, Adatya S, and Kapur NK. Use of percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. J Heart Lung Transplant 2018;37(1):100-106.
• Robert L. Gottlieb, MD, PhD, Teena Sam, PharmD, Suzanne Y. Wada, MD, James F. Trotter, MD, Sumeet K. Asrani, MD, Brian Lima, MD, Susan M. Joseph, MD, Gonzalo Gonzalez-Stawinski, MD, and Shelley A. Hall, MD. Rational heart transplant from hepatitis C donor: New antiviral weapons conquer the Trojan. J Cardiac Fail 2017 October; 23(10):765-767.
• Bindra A, Hall SA. New drugs for the treatment of heart failure. US Cardiol Rev 2017;11(2):62-6.
• Adesina GO, Hall SA, Mendez JC, Joseph SM, Gottlieb RL, Kale PP, Bindra AS. Arrhythmogenic right ventricular dysplasia: an under-recognized form of inherited cardiomyopathy. Rev Cardiovasc Med 2017;18)1):37-43.
• Lima, B, Dur O, Chuang, J, Chamogeorgakis, T, Farrar DJ, Sundareswaran KS, Felius J, Joseph SM, Hall, SA, and Gonzalez-Stawinski GV. Novel cardiac coordinate modeling system for three-dimensional quantification of inflow cannula malposition of HeartMateII LVADS.  ASAIO J 2017 July 25 (Epub ahead of print).
• Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O’Conner K, Reese P, Shelat K, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Vold M. The American Society of Transplantation Consensus Conference on the use of hepatitis c viremic donors in solid organ transplantation.  Am J Transplantation 2017 May 18;17(11):2790-802.
• Sandra Carey, PhD, Kyle Bass, MD, Givanna Saracino, MS, Cara A. East, MD, Joost elius, PhD, Paul A. Grayburn, MD, Ravi C. Vallabhan, MD, and Shelley A. Hall. Probability of accurate heart failure diagnosis and the implications for hospital readmission.  Am J Cardiol 5 Jan 2017;119(7):1041-6.
• Asad F. Shaikh, Susan M. Joseph, Brian Lima, Shelley A. Hall, Rajasekhar Malyala, Aldo E. Rafael, Gonzalo V. Gonzalez-Stawinski, and Themistokles Chamogeorgakis. HeartMate II left ventricular assist device pump exchange: A single-institution experience. Thoracic and Cardiovasc Surg 2017;65(5):410-4.
• John J. Squiers, Giovanna Saracino, Themistokles Chamogeorgakis, Juan C. MacHannaford, Aldo E. Rafael, Gonzalo V. Gonzalez-Stawinski, Shelley A. Hall, J. Michael DiMaio, and Brian Lima. Application of the International Society for Heart and Lung Transplantation (ISHLT) critera for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre.  Eur J Cardio-Thorac Surg 2017;51(2):263-70.
• Megan C. Reynolds, MS, Sandra Carey, PhD, Simon Driver, PhD, Jong Ko, BA, Joost Felius, PhD, William C. Roberts, MD, and Shelley A. Hall, MD. Patient acceptance of the Heart-t-Heart program: using patients’ native hearts to promote post-transplant health.  J Heart Lung Transplant October 2016; 35(10):1270-1271.
• George A. Heberton, MD, Michael Nassif, MD, Andrew Bierhals, MD, Eric Novak, MS, Shane J. LaRue, MD, Brian Lima, MD, Shelley Hall, MD, Scott Silvestry, MD, and Susan M. Joseph, MD. Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation. Am J Cardiol  12 Aug 2016 (Epub); 1 Nov 2016 (Print).
• Roberts Wc, Won VS, Vasudevan A, Kapoor P, Ko JM, Meyer DM, Hall SA, Gonzalez-Stawinski GV. Comparison of characteristics of patients undergoing heart transplantation at the same hospital in two different time periods (1997-2012 and 2013-2015). Am J Cardiol 15 July 2016;118(2):288-291.
• Themistokles Chamogeorgakis, Susie Joseph, Shelley Hall, Gonzalo V. Gonzalez-Stawinski, Giovanna Sacarino, Aldo Rafael, Juan MacHannaford, Ioannis Toumpoulis, Jose Mendez, and Brian Lima. Impact of donor age on cardiac transplantation outcomes and on cardiac function. Interact Cardiovasc Thorac Surg 31 May 2016;pii:ivw172.
• Carey, Sandra et al. Development of a squamous cell carcinoma of the hand and wrist after cardiac transplantation. Am J Cardiol 1 June 2016;117(11):1853-1854. Online 19 March 2016.
• Lima, Brian, Kale Parag, Gonzalo Gonzalez-Stawinski, Johannes Kuiper, Sandra Carey and Shelley Hall. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol 15 May 2016;117(10):1622-1628. Online 4 March 2016.
• William C. Roberts, Shelley A. Hall, Jong M. Ko, Peter A. McCullough, and Brian Lima. Atrophy of the heart after insertion of a left ventricular assist device and closure of the aortic valve. Am J Cardiol 1 March 2016;117(5):878-879.
• Sacks J, Gonzalez-Stawinski, GV, Hall S, Lima B, MacHannaford J, Dockery W, Cura M, and Chamogeorgakis T. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.  Interact Cardiovasc Thorac Surg November 2015;21(5):590-593.
• Reinhold, Stephanie M., Hall, Shelley A., Gonzalez-Stawinski, Gonzalo; Stoler, Robert C., Chamogeorgakis, Themistokles, and Khalid, Adnan. Heart transplantation in an Ehlers-Danlos patient. Proc – Baylor University Medical Center 2015;28(4):492-493.
• Armstrong, DO, Danielle, Gonzalez-Stawinksi, MD, Gonzalo, Ko, Jong Mi, Hall, MD, Shelley A., and Roberts, MD, William C. The two extremes of cardiac sarcoidosis and the effect of prednisone therapy. Am J Cardiol 8 September 2015;115:110-153.
• Chamogeorgakis, Themis, Hall, Shelley, and MacHannaford, Juan. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II Left Ventricular Assist Device. Eur J Cardiothorac Surg. 29 July 2015;pii:ivv205.
• Hall, Shelley A, Trungale, Kellis R., Dockery, Dee, and Gonzalez-Stawinski, Gonzalo V. Surgical management of inflow cannula misalignment in an LVAD patient. Clinical Case Report. Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute. 2015;1(2).
• Munkres AG, Ball TN, Chamogeorgakis T., Ausloos KA, Hall SA, and Choi JW. Usefulness of percutaneous closure of patent foramen ovale for hypoxia. Proc – Baylor University Medical Center. April 2015;28(2):204-206.
• Danielle Armstrong, DO, Gonzalo V. Gonzalez-Stawinski, MD, Jong Mi Ko, BA, Shelley A. Hall, MD, and William C. Roberts, MD. The two extremes of cardiac sarcoidosis and the effect of prednisone therapy. Am J Cardiol. 1 January 2015;115(1):150-153.
• Roberts WC, Roberts CC, Ko JM, Filardo G, Capehart JE, and Hall SA. Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnosis. July 2014;93(5):211-235.
• Erin E. Donaldson, DO, Jong Mi Ko, BA, Gonzalo Gonzalez-Stawinski, MD, Shelley A. Hall, MD, and William C. Roberts, MD. Secondary arrhythmogenic right ventricular cardiomyopathy decades after operative repair of tetralogy of fallot.  Am J Cardiol.  1 September 2014;114(5):806-809.
• Roberts WC, Chung MS, Ko JM, Capehart JE, Hall SA. Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation.  Am J Cardiol 15 February 2014;113(4):706-712.
• Monica S. Chung, BS, Jo Mi Ko, BS, Themistokles Chamogeorgakis, MD, Shelley A. Hall, MD, and William C. Roberts, MD. The Myth of the Burnheim Syndrome.  Baylor University Medical Center Proceedings October 2013 26(4):401–404.
• Roberts WC, Roberts CC, Ko JM, Grayburn PA, Tandon A, Kuiper JJ, Capehart JE, Hall SA Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation. Am J Cardiol June 2013;111(12):1818-1822.
• Afzal Nikaen, Nadim El-Awir, Judson Hunt, Edard Rosenthal, Eric Eichhorn, Shelley Hall, et al. Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices. J Heart Lung Transplant 2012;31:443-447.
• Roberts WC, Roberts CC, Ko JM, Hall SA, Capehart JE. Cardiac Transplantation in adults with aortic valve disease with focus on the bicuspid aortic valve.  Am J Cardiol 2012;109:1212-1214.
• Roberts WC, Karia SJ, Ko JM, Grayburn PA, George BA, Hall SA, Kuiper JJ, Meyer DM. Examination of isolated ventricular noncompaction (hypertracbeculation) as a distinct entity in adults.  Am J Cardiol 2011;108:747-752.
• Roberts WC, Ko JM, Kuiper JJ, Hall SA, Meyer DM. Some previously neglected examples of arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequency of its various reported manifestations.  Am J Cardiol 2010;106:268-274.
• Roberts MC, Vowels TJ, Ko JM, Capehart JE, Hall SA. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical “core” excised for insertion of a left ventriclar assist device for severe chronic heart failure.  Am J Cardiol 2009;103:110-114.
• Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R; FUSION II Investigators. Circ Heart Fail 2008;1: 9-16.
• Bolton DD, Hall SA, Roberts WC. Heart failure resulting from chemotherapy for testicular neoplasm: A follow-up on a patient reported 20 years earlier. Baylor University Medical Center Proceedings 2006;19:124-125.
• Young Janes B, Abraham William T, Smith Andrew L, Leon Angel R, Liberman, Randy, Wilkoff Bruce, Canby Robert C, Schroeder John S, Liem L Bing, Hall Shelley, Wheelan
  • Combined cardiac resynchronization and implantable cardioversion defribillation in advanced chronic heart failure: the MIRACLE ICD trial.  JAMA May 2003; 289(20):2685-2694.
• Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O’Connell JB, Schroeder JS and Wheelan KR. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction. Circulation.
• Bang LS, Black RD, Hall SA, Roberts WC. Dyspnea with hemoglobin SC disease.  Baylor University Medical Center Proceedings 2002;15: 86-90.
• Wheeler W, Hayes S, Nguyen N, Cilla AM, Rybowicz K, Jones CC, Ramsay MA, Hall SA, Meyer D, Capehart J, Jessen ME, Ring S. Sildenafil – a possible treatment for acute pulmonary hypertension during cardiac surgery. Baylor University Medical Center Proceedings 2002;15:13-15.
• Willett DL, Hall SA, Jessen ME, Wait MA, Grayburn PA. Assessment of aortic regurgitation by transesophageal color Doppler imaging of the vena contracta: validation against an intraoperative aortic flow probe.  JACC 2001;37:1450-1455.
• Heinle SK, Hall SA, Brickner ME, Willett D, Grayburn PA. Comparison of vena contracta width by multiplane transesophageal echocardiography with quantitative Doppler assessment of mitral regurgitation.  Am J Cardiol 1998;81:175-179.
• Main ML, Escobar JF, Hall SA, Killam AL, Grayburn PA. Detection of myocardial perfusion defects by contrast echocardiography in the setting of acute myocardial ischemia with residual antegrade flow.  J Am Soc Echo 1998;11:228-235.
• Main ML, Escobar JF, Hall SA, and Grayburn PA. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contract agent.  J Am Soc Echo November 1997;10(8):798-804.
• Slatton MK, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? JACC 1997; 29:1206-1213.
• Hall SA, Brickner ME, Willett DC, Afridi I, Grayburn PA. Assessment of mitral regurgitation by transthoracic color flow mapping of the bena contracta: comparison with quantitative Doppler. Circulation 1997;95:636-642.
• Main ML, Escobar JF, Hall SA, Grayburn PA. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.  J Am Soc Echo 1997;10:798-804.
• Hall SA, Cigarroa CG, Marcoux LG, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass, and geometry in patients with
  • congestive heart failure treated with b-adrenergic blockade. JACC 1995;25:1154-1161.

 

Book Chapters

• Susan M. Joseph, Marwa Sabe, and Shelley A. Hall. Outpatient / Long-Term Management of the LVAD Recipient. ISHLT Monograph Series – Mechanical Circulatory Support by Francis Pagani, MD, PhD, Stephan Schueler, MD, PhD, FRCS, Nir Uriel, MD, MCs, Simon Matltais, MD, PhD, eds.  (James Kirklin, MD, series ed.). University of Alabama at Birmingham (UAB) Printing.  Volume 14, Chapter 11.
• Shelley Hall, MD, Amit Alam, MD, Deborah Levine, MD, and Yaron Barac, MD. Transplant Organizations, Oversight, Structure and Process; Worldwide Perspective.. (pending publication).
• Melody Sherwood, MD and Shelley A. Hall, MD, FACC. Percutaneous Devices: Options. Mechanical Circulatory Support in End Stage Heart Failure: A Practical Guide by Montalto, Antonino Loforte, Francesco Musumeci, Thomas Krabatsch, Mark Slaughter, and Cristiano Amarelli, eds. Springer. 2017 July 11.

 

IRB Projects Ongoing

• Trifecta-Heart cfDNA-MMDX Study: Comparing the DD-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test– Role: PI           
• Prospera Test Evaluation in Cardiac Transplant (ProTECT)– Role: National PI 
• Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab (All-In) – Role: PI 
• Surveillance Heartcare® Outcomes Registry (Shore) – Role: PI 
• A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of inhospital initiation of LCZ696 compared to valsartan in HFpEF patients with acute decompensated heart failure (ADHF) who have been stabilized during hospitalization (PARAGLIDE- HF) – Role: PI 
• Nationwide Hepatitis C NAT+ Cardiac Transplant Experience – Role: National PI 
• Phase II, Single-Center, Open-Label Study Evaluating The Comparable Efficacy Of Tacrolimus Extended Release Tablets (Envarsus®) To The Standard Of Care (Soc) Twice Daily Tacrolimus (Prograf®) Dosing Regimen – Role: PI 
• Umbrella National & Regional Population Database Studies Protocol – Role: PI 
• Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF) – Role: PI 
• Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients (TROJAN-C) – Role: National PI 
• A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency (Heart-FID) – Role: PI 
• Antiplatelet Removal and Hemocompatibility Events with the HeartMate3 Pump (ARIES HM3) – Role: PI        
• Primary Graft Dysfunction International Consortium – Role: PI
• The Cardiogenic Shock Working Group Registry– Role: PI
• A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance (Meteoric-HF) – Role: Co-I 
• A Prospective Study To Evaluate The Safety And Efficacy Of The Evaheart LVAS For Use As A Bridge-To-Transplant – Role: Co-I 
• Intermacs - Interagency Registry for Mechanically Assisted Circulatory Support – Role: Co-I 
• Protocol to conduct a broad range of retrospective data reviews on heart transplant, lung transplant, ventricular assist devices (VADs), advanced heart failure and cardiology – Role: Co-I 
• HeartWare Endurance Trial HW004-A: A Prospective, Randomized, Controlled, Unblinded, Multi-Centered Clinical Trial to evaluate the HeartWare Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure – Role: Co-I 
• REDUCE LAP-HF RANDOMIZED TRIAL II: A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure –Role: Co-I 
• Baylor Extracorporeal Membrane Oxygenation Research Program – Role: Co-I
• Carmat Total Artificial Heart Early Feasibility Study– Role: Co-I
• Prospective non-randomized post market study collecting clinical data on safety and effectiveness of the remedē® System – Role: Co-I
• AlloSure test characteristics in immunologically quiescent and immunologically active heart transplant recipients: Does maximal cardiopulmonary stress testing prior to assay preserve test specificity while enhancing sensitivity? – Role: Co-I
• De Novo Anti - Human Leukocyte Antigen Antibodies Production in Patients Bridged by Temporary Mechanical Circulatory Support Devices to Orthotopic Heart Transplantation: A Prospective Analysis – Role: Co-I
• Use of dd-cfDNA in Multi-Organ Transplant Rejection Detection (MOTR) – Role: Co-I
• A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients Who Have Been Stabilized During Hospitalization for Acute Heart Failure – Role: Co-I
• How Does Living with an LVAD Affect a Couple’s Sexual Quality of Life? – Role: Co-I
• Assessment of Implantable CCM in the Heart Failure Group with Higher Ejection Fraction – Role: Co-I
• Behavioral Health Risk Assessment Scoring in the Advanced Heart Failure Patient Population Seeking Either Left Ventricular Assist Device or Orthotopic Heart Transplantation (BHR score in Advanced HF) – Role: Co-I

 

 

IRB Projects Closed/Completed

• Therapy with HeartMate 3™-Continued Access Protocol – Role: PI
• A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study (NuPulse iVAS) – Role: Co-I
• Allomap® And Endomyocardial Biopsies: The Patient Experience – Role: Co-I
• Shear Wave Elastography of the Liver and Prediction of Morbidity and Mortality in Subjects Undergoing Advanced Heart Failure Therapy – Role: Co-I
• Effects of dapagliflozin on biomarkers, symptoms and functional status in patients with PRESERVED ejection fraction Heart Failure – Role: Co-I
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF – Role: Co-I
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction – Role: Co-I
• Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients – Role: Co-I
• ToRsemide compArisoN with furoSemide FOR Management of Heart Failure – Role: Co-I
• Extension of the Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation, a Multicenter Study (INTERHEART-EX) – Role: PI
• A prospective, multicenter, double-blind, randomized placebo-controlled, parallel-group study to assess the efficacy and safety of macitentan in patients with pulmonary hypertension after left ventricular assist device implantation (Soprano) – Role: PI
• The Impact of using CardioMEMS for Heart Failure (HF) Patients in a Large Health Care System: A Registry – Role: PI
• MOMENTUM 3: Multi-Center Study of MagLev Technology in Patients Undergoing MCS – Role: PI
• TandemHeart® Experiences and MEthods THEME Registry™ – Role: PI
• A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency – Role: PI
• Bio-Banking of Specimens for Cardiovascular Research – Role: PI
• HeartWare Endurance Trial HW004-A: A Prospective, Randomized, Controlled, Unblinded, Multi-Centered Clinical Trial to evaluate the HeartWare Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure – Role: Co-I
• SYNCARDIA 50cc TAH-t for Bridge to Transplant – Role: Co-I
• Outcomes AlloMap Registry (OAR) study and sub study: Utility of Donor-Derived Cell-free DNA in Association with Gene-Expression Profiling (AlloMap) in Heart Transplant Recipients (D-OAR) – Role: PI
• MOMENTUM 3 IDE Clinical Study – Role: PI
• Impact of Preoperative Renal Dysfunction on Outcomes Following Cardiac Surgery – Role: PI
• A multicenter, randomized, double-blind, double dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril and valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability of in-hospital initiation of LCZ696 compared to enalapril in HFrEF patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF) (PIONEER-HF) – Role: PI
• Pre-discharge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF) – Role: PI
• An exploratory, randomized, double-blind, placebo-controlled, parallel arm trial of the safety and pharmacodynamic activity of sotagliflozin in hemodynamically stable patients with worsening heart failure (PDY15079) – Role: PI
• The Effect of Patient Activation on Self-Management in Patients Receiving Advanced HF Therapies (Left Ventricular Assist Device (LVAD) and Cardiac Transplant) – Role: Co-PI
• A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare® Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure – Role: Co-I
• PREVENTion of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy – Role: Co-I
• The Global cVAD Registry Protocol, Impella Family of Devices: Impella 2.5, Impella CP, Impella 5.0 Impella LD, and Impella RP – Role: Co-I
• CardioMEMs HF System Post Approval Study – Role: PI
• Validation of PICC derived Fick cardiac output in patients with heart failure – Role: Co-PI
• Multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved Ejection fraction – Role: Co-PI
• Thoratec SSI. Participating center – Role:  PI
• Impella RP Study – Role: PI
• Zensu NOVEL-HF2 Neuregulin-1 Effects on Survival and Hospitalization in Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) (NOVEL-HF2) – Role: PI
• The Impact of Sleep Apnea Syndrome Post Cardiac Transplantation – Role: PI
• Secondary Traumatic Stress, Compassion Fatigue, and Burnout in Transplant Clinicians –Role: Co-I
• Utility of Cardiac Computed Tomography for Inflow Cannula Patency Assessment and Prediction of Clinical Outcome in Patients with the HeartMate II Left Ventricular Assist Device – Role: Co-PI
• Heart Transplantation in the Ehlers-Danlos Syndrome – Role: Co-PI
• ASCEND Trial. Participating center.
• Clinical Investigation of the MicroMed DeBakey VAD for Bridge to Transplantation in Patients with Endstage Heart Failure
• STICH Trial. Participating center.
• RED-HF Trial. Participating center.
• REDUCE HF. Participating center.
• IMPROVE HF. Participating center.
• Double-blind placebo controlled, randomized study to assess the efficacy and safety of Zenapax in combination with cellcept, cyclosporine and corticosteroids in patients undergoing cardiac transplantation
• COMPANION trial. Participating center.
• STAMINA-HFP (Study of Anemia in a Heart Failure Population). Participating center.
• ADHERE Registry. Participating center.
• Randomized evaluation of mechanical assistance for the treatment of congestive heart failure.
• EPHESUS Trial. Eplerinone post-myocardial infarction heart failure efficacy and survival study.
• MIRACLE In-SyncTM: clinical study evaluation of cardiac resynchronization therapy for heart failure patients with ICD indications
• Continued Access Protocol of the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
• SCD-HeFT. Participating center.
• The Use of Natrecor in Conjunction with Standard Therapy as a Pharmacological Bridge to Transplantation – single center case study.
• DeNovo Prospective, Randomized, Multi-Center Comparison of PRograf, Cellcept, and Steroids vs Cyclosporine (modified, USP), Cellcept and Steroids vs. Prograf, Rapamune and Steroids in DeNovo Cardiac Transplant Recipients.
• HF- Action (Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training. Participating center.
• FUSION II. Participating center.
• DIT-803. Trial Investigating Thyroid Abnormalities and Heart Failure.  Participating center.
• The Effects of Nitric Oxide for Inhalation During Orthotopic Heart Transplantation
• The Effects of Nitric Oxide During Left Ventricular Assist Device Implantation
• Participating Center. PI. (March 2016)
• Bayer 16275 FINESSE Heart Failure Study. PI. – Study cancelled. (March 2016)

 

Abstracts / Posters Presented

• Hall, Shelley A. Use of Impella 5.0 Ventricular Assist Device as a Bridge to Decision during Acute Decompensation of End-Stage Chronic Heart Failure.  Mini Oral Presentation. 2016 International Society of Heart and Lung Transplantation (ISHLT); Marriott Wardman Park Hotel, Washington, DC.  April 28, 2016.

 

• Silvestry SC, Edwards LB, Robbins L, Hall SA, Rogers JG, and Meyer, DM. Outcomes in Adult Heart Transplant Candidate & Recipients Bridged with Acute Circulatory Support Devices. (Poster) 2015 Annual Meeting, International Society of Heart and Lung Transplantation (ISLHT); Nice, France.  April 2015.

 

• Carey Sandra, Nazia Iram, Giovanna Saracino, Shelley A. Hall. Utilization of Cardiac Tomography to Assess Predictability of Device Thrombus in Patients with a Left Ventricular Assist Device (LVAD). (Poster) 60^th Annual American Society for Artificial Internal Organs Conference (ASAIO) June 20, 2014.

 

• Feldman David, Uriel Nir, Pinney Sean, Teuteberg Jeff, Crumbley Arthur, Hall Shelley, Starling Randall, Deng Mario C, Crespo-Leiro Maria G, Vanhaecke Johan, Stypmann Jorg, Hiller David, Arnold PJ and Yee James. Gene Expression Profiling Test (GEP) Scores and Outcomes of Heart Transplant with Prior Mechanical Circulatory Support: Results from IMAGE and CARGO II. Poster Session I: Mechanical Circulatory Support. ISHLT April 10, 2014.

 

• Hall SA, Kuiper JJ, Hardaway B. Outpatient Inotropes:  An Ever-Lengthening Bridge to Transplant.  Poster International Society of Heart and Lung Transplantation (ISHLT) April 2013.

 

• Hall SA, Hardaway BW, Meyer D, Bethea B, Kuiper JJ. Reducing length of stay in the Heartmate II era.  (Poster) HFSA Sept 2012.

 

• Hall SA, Kuiper JJ, Grimsley B, Pearl G, Matter G, Hamman B, Hardway BW. The use of Impella 5.0/LD in the management of heart failure patients with cardiogenic shock:  a multidisciplinary team approach.  (Poster) HFSA Sept 2012.

 

• Hall SA, Gonzalez-Stawinski G, Meyer D, Bethea B, Kuiper JJ, Hardaway BW. Unplanned hospital readmissions and continuous flow pump therapy.  (Poster) HFSA Sept 2012. 

 

• Dunlap, Stephanie H., Pina, Ileana L., Cotts, William G., Wagoner, Lynne E., Oren, Ron M., Gattis Wendy A., Mehra, Mandeep R., Ghali, Jalal K., Hall, Shelley A., Felker, G. Michael, Schwartz, Todd A., Hunter, John A., and Adams, Kirkwood A, STAMINA-HFP Investigators. Lower hemoglobin is associated with persistently reduced quality of life in unselected patients with heart failure: Results from the study of anemia in a heart failure population (STAMINA-HFP) Registry. Jnl of Cardiac Failure 2004; 10:S102.

 

• Willett DL, Hall SA, Brickner ME, Jessen ME. Quantitation of aortic regurgitation by color flow mapping of the vena contracta: intraoperative validation in man.  Circ 1996; 94: I-492.

 

• Hall SA, Cigarroa CG, Marcoux LG, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular volumes and ejection fraction with metoprolol therapy in dilated cardiomyopathy. Circ 1994; 90: I-543.

 

Presentations

 

• UNOS Emergency Policy Change. ISHLT Industry Seminar with Medtronic.  Review of the HVAD Landscape Since June 2021. December 13, 2022
• Cell-Free DNA: What Does it Add to Diagnosing Rejection. Presenter. Houston Methodist symposium – Rejection of the Heart: New Frontiers in Diagnosis and Treatment. Houston, TX.  November11, 2022
• Protocol-Driven Approach to Management of Shock Patient: SCAI Perspective.  Keynote Lecture.  Louis Shock & Heart Failure Symposium.  St. Louis, MO.  October 29, 2022.
• Session II: Advanced Heart Failure: Definitions and Initial Treatments.  Co-Moderator.  Louis Shock & Heart Failure Symposium.  St. Louis, MO.  October 29, 2022.
• Current Tweaks and Works in Progress in the US Heart Transplant Allocation System. Presenter. Session 12.  Heart Transplant Allocation in 2022.  HFSA 2022 Annual Scientific Meeting.  Boston, MA.  October 2, 2022.
• Demographics and Statistics of Patients with HCM in the US. Presenter and Content   Session 2.  The American College of Cardiology Cardiovascular Masters Program: Hypertrophic Cardiomyopathy. Baylor Heart and Vascular Hospital.  Dallas, Texas.  June 22, 2022.
• Challenges of Identifying HCM in Real-World Practice in this Health System. Presenter and Content Expert. Session 5. The American College of Cardiology Cardiovascular Masters Program: Hypertrophic Cardiomyopathy. Baylor Heart and Vascular Hospital. Dallas, Texas.  June 22, 2022.
• Out with the Old, In with the New! Histopathology is so 1980s! Rebuttal:Pro. Session: Donor-Derived Cell Free - DNA - Thinking Outside of the Box: Lessons to be Learned.  ATC2022, John B. Hynes Convention Center, Boston, MA.  June 5, 2022.
• Case #8 and Case #9 Management of End Stage Heart Failure. Panelist. Cases and Controversies in Heart Failure 2022.  NYU Langone Health. NYU Grossman School of Medicine, Continuing Medical Education.  May 6, 2022.  (virtual).
• Case #10 and Case #11 Cardiogenic Shock. Moderator. Cases and Controversies in Heart Failure 2022.  NYU Langone Health. NYU Grossman School of Medicine, Continuing Medical Education.  May 6, 2022.  (virtual).
• Triaging of patients with Heart Failure: Mechanical Assistance or Transplant? A US vs European View.  Co-Speaker.  Heart Failure Online 2022 (Session 4).  (virtual).  May 5, 2022.
• Beyond the Surface: Non-Invasive Diagnostics for Rejection Surveillance. Speaker.  ISHLT 42^nd Annual Meeting & Scientific Sessions.  Boston, MA.  April 30, 2022.
• Diagnostic and Therapeutic Recovery Strategies in Acute HF and Shock. Co-Chair.   Utah Cardiac Recovery Symposium (U-CARS).  March 25, 2022.
• Development of an International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Ear of Heart Transplantation. Oral Session 08: Dysfunction Junction in Heart Transplantation.  ISHLT 41^st Annual Meeting & Scientific Sessions.  April 25, 2021.
• Kathleen Kopecky, Christo Mathew, Timothy Gong, Daniel Enter, Maysoon Shalabi-McGuire, Brittan Blough, Amit Alam and Shelley Hall. Drugs, Bugs, and the ECMO Unplugged: A Case of a 61-year old with Cardiogenic Shock and Utility of Palliative Bedside ECMO De-Escalation.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Ronak Rengarajan, MD, Greggory Milligan, MD, Nicole Minniefield, MD, Daniel Cheeran, MD, Subhas Banerjee, MD, Shelley Hall, MD, Susan Joseph, MD, and Amit Alam, MD. “The Road Not Taken”: Successful Use of CardioMEMS to Optimize a Patient in Stage D Heart Failure.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• C. DePasquale, J. Kobashigawa, S. Hall, T. Wolf-Doty, J. Teuteberg, and K.K. Khush. Donor Derived Cell Free DNA as a Risk Factor in Initiating De-Novo Donor Specific Antibodies in Heart Transplantation. (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• K. Khush, K.B. Shah, A. Kao, S. Ghosh, L. Lourenco Jenkins, D. Baran, S. Pinney, and S. Hall. Racial Disparities in Gene Expression Profiling but Not Donor-Derived Cell-Free DNA after Heart Transplantation.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Aayla K. Jamil, MB, BS, MPH, Kristen M. Tecson, PhD, Tatyana T. Ganz, MD, Shane R. Blankenship, Joost Felius, PhD, Sandra A. Carey, PhD, and Shelley A. Hall, MD. AlloMap® Versus Endomyocardial Biopsy: The Patient Experience. (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Keighly Bradbrook, PhD, Kelsi Lindbald, PhD, R.R. Goff, PhD, R. Daly, MD, and S. Hall, MD. Insights into the Impact of Modifications made to the Adult Heart Allocation Policy in the US at 18 Months.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• A Novel Protocol for the Evaluation and Management of Patients for Successful HeartMate III Explantation (WITHDRAWN). ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Anas Hamadeh, Gregory P. Milligan, Nicole E. Minniefield, Daniel Cheeran, Subhash Banerjee, Shelley Hall, Susan Joseph, and Amit Alam. Variation in CardioMEMS Pressure Measurements Due to Frequent Changes in Altitude in a Patient with HeartMate III LVAD.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Elie Dib, MD, Susan Joseph,, MD, Nishi Patel, MD, Aldo Rafael, MD, Dan Meyer, MD, Amarinder Bindra, MD, Shelley Hall, MD, and Timothy Gong, MD. Left Ventricular Assist Device Implantation in a COVID-19 Positive Patient. (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Gregory P. Milligan, Nishi Patel, Timothy Gong, Christo Mathew, Shelley Hall, Subhash Banerjee, Nicole Minniefield, Rita Jermyn, Katherine Michelis, Daniel Cheeran, and Amit Alam. Procedural Safety Profile of CardioMEMS Heart Failure Sensor Implantation in a Veterans Association Patient Population.  (Poster) ISHLT 41^st Annual Meeting & Scientific Sessions. April 2021.
• Hall, Shelley. Prolonged Support with Temporary VAD for Native Heart Recovery. U-CARS Symposium 2021. March 18, 2021.
• The Dark Side of the Moon: Non-Ischemic Shock. Q&A Moderator.  SCAI Shock:  Cardiogenic Shock: Breaking the 50% Mortality Barrier 2021.  October 7, 2021.
• V A ECMO: One Size Fits All. Speaker. SCAI Shock: Cardiogenic Shock: Breaking the 50% Mortality Barrier 2021.  October 7, 2021.
• Part 2: Cardiogenic Shock – Temporary Mechanical Support Options and the Shock Team. Advanced Heart Failure CME Lecture. Baylor University Medical Center.   September 9, 2021. 
• Part 1: Pharmacological Management of Cardiogenic Shock – SCAI Shock Scores. Speaker. Advanced Heart Failure CME Lecture.  Baylor University Medical Center.  July 8, 2021.
• Principles of Cardiogenic Shock. Speaker. Baylor Scott and White Health Cardiovascular Internal Medicine Conference. June 25, 2021.
• Organ-specific allocation policies: Heart. Speaker.  Sex Disparities in Organ Allocation: Leveling the Playing Field.  University of Colorado.
• The Times, They Are a Changing: Heart. Speaker. ATC 2021. June 4, 2021.
• Don’t Throw Them in the Bucket!!! Tricks of the Trade to Optimize Every Thoracic Donor Offer. Moderator. ATC 2021.  June 4, 2021.
• Role of Biomarkers in Current Clinical Practice – Remote Monitoring for the Spectrum of Solid Organ Transplantation. Moderator. ATC 2021.  June 5, 2021
• Examine Well Your Blood: Heart Transplant Management Without a Biopsy. Moderator. ATC 2021.  June 6, 2021.
• Cardiogenic Shock. Cardiovascular Grand Rounds.  CHI St. Vincent Hospital – Little Rock (Hub).  May 21, 2021.
• Best MCS Strategy for RV and BiV Shock. Speaker. Session #727: Cardiogenic Shock: Teams and Devices for Cardiogenic Shock. ACC 70^th Annual Scientific Session.  May 16, 2021.
• The Future for Advanced Heart Failure Patients. Speaker. Yale University’s “How Experts Manage Heart Failure” Series.  May 5, 2021.
• Will This Heart Beat Again? Who Will Recover and Who to Transplant. Speaker. ISHLT 41^st Annual Meeting & Scientific Sessions. Symposium 39 – Short-term MCS in Bridging the Gap Between Recovery and Transplant.  April 28, 2021.
• Use of Donor-Derived Cell-Free DNA to Remotely Monitor Allograft Status in Cardiac Transplant Recipients. Speaker. ISHLT 41^st Annual Meeting & Scientific Sessions. Symposium 36 – Tales for the Plague Year: Remote Monitoring of Heart Transplant Recipients.  April 28, 2021.
• Mini Oral Session 04: Interesting Things to Do to Improve Heart Pre- and Post- Transplant Outcomes. Co-Chair.  ISHLT 41^st Annual Meeting & Scientific Sessions. April 26, 2021.
• 2021 Cardiogenic Shock. Dallas Cardiology Grand Rounds.  Baylor Heart and Vascular Hospital.  April 19, 2021.
• PA Catheter Should be Used in All Patients with Cardiogenic Shock: PRO. AHA2020 Nov 15, 2020
• Use of Hepatitis C Virus+ NAT+ Donor Hearts in Heart Transplant Recipients. AHA2020, Nov 13, 2020
• Heart Transplantation. Internal Medicine Grand Rounds. Methodist Dallas Medical Center. November 7, 2019.
• The Growing World of tMCS. Advanced Heart Failure Lecture Series. Baylor University Medical Center. October 31, 2019.
• Stranger in a Strange Land: HF in an Interventional World. 2019 Cardiovascular Conference HEART of Battle: Sentara Shock Symposium.  Sentara Heart.  Norfolk Hilton, The Main.  Norfolk, VA. October 19, 2019.
• The New Heart Allocation System. Heart Failure Society of America 23^rd Annual Scientific Session.  Pennsylvania Convention Center.  Philadelphia, PA.  September 16, 2019.
• Acute Management of Cardiogenic Shock. Chair.  Heart Failure Society of America 23^rd Annual Scientific Session.  Pennsylvania Convention Center.  Philadelphia, PA.  September 16, 2019.
• Heart Transplant: The Beat Goes On, Over 50 Years of Heart Health. Panelist. 10^th Annual CME Review Course of Advances in Heart Failure, Mechanical Circulatory Support & Transplantation. CATCH-UP 2019: Heart Failure, Devices and Interventions.  Columbia University Irving Medical Center / New York Presbyterian.  New York, NY.  May 3-4, 2019.
• How Hepatitis C-Positive Heart Transplants Could Help Address the Organ Donor Shortage. 10^th Annual CME Review Course of Advances in Heart Failure, Mechanical Circulatory Support & Transplantation.  CATCH-UP 2019: Heart Failure, Devices and Interventions.  Columbia University Irving Medical Center / New York Presbyterian.  New York, NY.  May 3, 2019.
• Stayin’ Alive: Bridging the Heart Failure Patient to a Transplant. SCAI 2019 Scientific Session.  Las Vegas, NV.  May 21, 2019
• Team Approach to a Cardiogenic Shock Patient: Collaboration with Advanced Heart Failure Team. 5^th Annual Heart Failure Symposium. Methodist Heart. Grand Hyatt San Antonio. March 2, 2019.
• HF Cardiologist’s View : The Ideal Study Design. 7^th Annual Utah Cardiac Recovery Symposium (U-CARS) 2019.  Salt Lake City, UT.
• Post Transplant Care. Advanced Heart Failure CME Lecture. Baylor University Medical Center. January 31, 2019.
• UNOS Allocation Changes. Advanced Heart Failure CME Lecture.  Baylor University Medical Center. December 6, 2018.
• Cardiogenic Shock. RSS Program. Baylor University Medical Center. October 15, 2018.
• Pharmacologic and device-based approaches to acute heart failure and cardiogenic shock. Boston Hemodynamics Course on Shock. June 29, 2018.
• Expand Your Donor Pool: Utilization of Hep C+ Organs. Annual AOPO Meeting.  Washington DC.  June 19, 2018.
• Debate on Hep C + Donors: Pro. American Transplant Congress. June 4, 2018.
• Lessons Not Learned: We Still Have Much to Do. Abbott User Meeting.  Phoenix, AZ. May 19, 2018.
• Updates in Heart Failure 2018. Portuguese Congress of Cardiology. Algarve, Portugal.  April 29, 2018.
• Advanced Heart Failure. Portuguese Congress of Cardiology. Algarve, Portugal. April 28, 2018.
• Cardiogenic Shock and Short-term MCS: Veno-Arterial ECMO: Indications and Surveillance. April 13, 2018.
• Using Complementary Approaches in Clinical Practice: AlloMap and AlloSUre-Heart. ISHLT. Nice, France. April 11, 2018.
• Cardiogenic Shock. ISHLT Academy. San Diego, CA. April 10, 2018.
• Percutaneous Support Devices in Shock. April 6, 2017.
• Palliative Care for Advanced Heart Failure:  An Ethical Discussion. Longview Regional Medical Center.  Longview, TX. March 30, 2017.
• Surgical Therapies for HF Patients: Stage A-C. Co-Chair.  American College of Cardiology (ACC) 66^th Annual Scientific Session. Marriott Marquis, Washington, DC.  March 17-19, 2017. 
• Indications for Percutaneous Temporary Support of Severe Congestive Heart Failure. NCVH Shreveport 2017, Session III. Shreveport Convention Center, Shreveport, LA.  February 17, 2017.
• Palliative Care Approaches With Advanced Heart Failure. Complex Care:  Treatment Trends and Improved Outcomes, Baylor University Medical Center Primary Care/Specialty CME, Shreveport, LA. February 18, 2017.
• Acute Decompression in Heart Failure. Cardiology Grand Rounds.  Baylor Jack and Jane Hamilton Heart and Vascular Hospital.  Dallas, TX.  October 24, 2016.
• CHF: Treatment & Trials. Annual Research Awareness Week program. Baylor University Medical Center.  17 Roberts.  Dallas, TX. March 9, 2016.
• Cardiac Transplant Overview. The 3^rd Annual Quality Summit. Integrative Emergency Services. Irving Convention Center at Las Colinas. Las Colinas, TX. February 20, 2016.
• Advanced Heart Failure and VAD. Re-Start Your Heart Event. Hilton Garden Inn. Temple, TX. February 18, 2016.
• Management of Acute Decompensated Heart Failure Medicines and Devices. Contemporary Management of Cardiovascular Disease.   Baylor Scott & White Health and Cleveland Clinic Heart and Vascular Institute.  Hilton Anatole Hotel.  Dallas, TX.  November 20, 2015.
• Advanced Heart Failure. Transfer Center Nursing Education.  Baylor University Medical Center.  Dallas, TX.  November 4, 2015.
• Heart Transplantation. Select Specialty Hospital.  Baylor University Medical Center.  Dallas, TX.  October 20, 2015.
• Update in Heart Failure Management. American College of Cardiology (ACC) 2015 Annual Meeting – Texas Chapter.  JW Marriott Hotel.  San Antonio, TX.  October 3, 2015.
• Thoratec Corporation. Bob’s Steak and Chop House.  Dallas, TX.  August 18, 2015.
• IMPELLA Devices. Cardiology Grand Rounds.  Baylor University Medical Center.  Dallas, TX. August 17, 2015.
• Advanced Heart Failure. Cardiology Grand Rounds. Baylor University Medical Center. Dallas, TX. July 20, 2015. 
• Current Therapies by Drug Class. Novartis Cardiology Education Program. Baylor Heart and Vascular Hospital. Dallas, TX.  June 10, 2015.
• Point-Counter Point Discussion – Dr. Jose Mendez vs Dr. Amarinder Bindra. Moderator. Novartis Cardiology Education Program. Baylor Heart and Vascular Hospital. Dallas, TX. June 10, 2015. 
• Point-Counter Point Discussion “Art v Science” of Management. Moderator. Novartis Cardiology Education Program. Baylor Heart and Vascular Hospital.  Dallas, TX.  May 19, 2015.
• Hemodynamic Support for Advanced Heart Failure. Cardiovascular Innovations 2015. Dallas, TX.  January 16, 2015. 
• Drugs, Devices, and Hearts for Heart Failure: An Exciting Era. The 41^st Annual Williamsburg Conference on Heart Disease. Williamsburg, VA.  December 8, 2014. 
• Advanced Heart Failure Therapy Today. Grand Rounds. Baylor All Saints. Fort Worth, TX. November 11, 2014.
• Advanced Heart Failure Therapy Today. HeartMateII Program.  Phoenix, AZ.  November 7, 2014. 
• The Advanced Heart Failure Patient: Their Impact on Readmissions and How to Identify Them. Heart Failure Readmission Symposium, American Association of Heart Failure Nurses (AAHFN).  Dallas, TX.  October 18, 2014. 
• A Bird’s-eye View of the Guidelines and Management of Chronic CHF. Hendrick Medical Center.  The 19^th Annual Physician CME Symposium.  Hendrick Medical Center, Abilene, TX.  September 19, 2014.
• Advanced Heart Failure Symposium 2014. Medical Director.  Dallas, TX.  February 22, 2014.
• Therapeutic Options for Advanced Congestive Heart Failure. Grand Rounds.  Hendrick  Medical Center.  Abilene, TX.  February 20, 2014.
• Advanced Congestive Heart Failure: Current Treatment Options. The 40th Annual Williamsburg Conference on Heart Disease.  Williamsburg, VA.  December 9, 2013. 
• Cardiothoracic Transplantation. Grand Rounds.  The Heart Hospital Baylor Plano. Plano, TX.  December 12, 2013. 
• Internal Medicine Grand Rounds.   Baylor University Medical Center. Dallas, TX.  August 2013. 
• LVAD and Palliative Care. Baylor University Medical Center. Journal Club. Dallas, TX. August 2013. 
• LVAD 101. Baylor University Medical Center.  Dallas, TX. February 2013.
• Baylor University Medical Center. Dallas, TX.  August 2012. 
• Acute Decompensated Heart Failure. Baylor University Medical Center.  Dallas, TX. July 2012. 
• Updates on Baylor Congestive Heart Failure. Baylor University Medical Center. Dallas, TX. May 2012. 
• Introduction to LVADs. Baylor University Medical Center.  Dallas, TX.  January 2012. 
• Evaluation for Candidacy and Complications. Baylor University Medical Center. Dallas, TX.  June 2011. 
• Therapeutic Options in End-Stage Heart Failure. Baylor University Medical Center.  Dallas, TX.  January 2011. 
• Congestive Heart Failure. Baylor University Medical Center.  Dallas, TX.  September 2008.  
• Current Guidelines in Cardiac Care. Baylor University Medical Center.  Dallas, TX.  June 2007. 
• Newest Advances in the Treatment of Acute Decompensated Heart Failure. Baylor University Medical Center.  Dallas, TX.  July 2006. 
• Acute Decompensated Heart Failure. Baylor University Medical Center.   Dallas, TX.  August 2005. 
• Cardiovascular Care. Post Transplant Patients. Baylor University Medical Center.  Dallas, TX.  December 2005. 
• Stage A CHF. Baylor University Medical Center.  Dallas TX.  October 2004.
• Decompensated CHF. Baylor University Medical Center.  Dallas, TX.  March 2004. 
• Congestive Heart Failure. Baylor University Medical Center.  Dallas, TX.  March 2004. 

 

TEXAS A&M HEALTH SCIENCE CENTER / COLLEGE OF MEDICINE - FACULTY DEVELOPMENT

FY 2023

• Fall 2022 AAMC Medical Education Webinar Series: Technique over Recipe:  Using Guiding Principles to Inform Well-Being Interventions. September 14, 2022 (1.0 FD Credit / 1.0 AMA PRA Category 1 Credit).
• IAMSE Fall 2022 Webinar Series – The Struggle is Real: Breaking Barriers that Limit Students Success, Mental Health, and the Struggling Learner. Michael Redinger, MD, MA.  September 15, 2022 (1.0 FD Credit / 1.0 AMA PRA Category 1 Credit).
• ADME Medical Education Journal Club, Suicide Among Healthcare Teams & Trainees: Risk Reduction Through Awareness, Transparency, and Modeling Vulnerability with Rob Carpenter, MD. September 15, 2022 (1.0 FD Credit / 1.0 AMA PRA Category 1 Credit).

FY 2022

• Advancing Through the Ranks: Promotion Pathway for Affiliate Faculty. Medical Education Grand Rounds.  Diane E. Chico, Ph.D. (presenter).  February 24, 2022.  (1.0 FD/ 1 AMA PRA Category 1).
• The Use of Social Media in Undergraduate Medical Education. TAMU Medical Education Journal Club. Jack Myers, MD (presenter).  February 24, 2022. (1.0 FD/ 1 AMA PRA Category 1).
• Compassion Fatigue: The Cost of Caring for Others! TAMU Com Health and Wellbeing Grand Rounds.  Thomas Cox, Psy.D. (presenter).  February 22, 2022. (1.0 FD/ 1 AMA PRA Category 1).
• Compassion Fatigue: The Cost of Caring for Others! GME Grand Rounds. Thomas, Cox, Psy.D. (presenter).  January 27, 2022. . (1.0 FD/ 1 AMA PRA Category 1).

FY 2021

• How to Make Your Presentations More Engaging: Effective Communication Skills for Health Educators. Education Grand Rounds.  October 8, 2020. (1.0 FD/ 1 AMA PRA Category 1). 
• To Best Lead Others, First Lead Yourself. Major General David Rubenstein, FACHE, US Army (retired), TAMU COM Military Medicine series of Distinguished Speakers.  September 30, 2020. (1.0 FD/ 1.0 AMA PRA Category 1 / Ethics Credit).
• Professionalism in Physicians. Belinda Kohl-Thomas, MD (presenter). November 12, 2020.  (1.0 FD/ 1 AMA PRA Category 1). 
• How to Free Your Mind and Become the Person You Want to Be! December 1, 2020. (1.0 FD).
• Ensuring a Respectful and Harassment-Free Learning Environment. Medical Education Grand Rounds.  Natalie Gittus, JD (presenter).  April 29, 2020. (1.0 FD/ 1 AMA PRA Category 1).

FY 2020

• Artificial Intelligence in Medical Education by Van Wilson, PhD. April 16, 2020. (1.0 FD / AMA PRA Category 1)
• Leading From Your Strengths in an Emerging Healthcare Crisis. April 23, 2020 (1.5 FD / AMA PRA Category 1 in Medical Ethics and/or Professional Responsibility)
• Understanding Intersectionality: Bringing Visibility to the Experiences and Perspectives of Women of Color. Toi Harris, MD, Chiquita A. Collins, PhD, Yolonda Y. Wilson, PhD, and Valencia Walker, MD (speakers). August 7, 2020 (1.0 FD)

FY 2019

• "Flip the Pimp" Pearls for Outstanding Bedside Teaching. November 18, 2019.
• Professionalism in the 21st Century. November 18, 2019. (.5 FD)
• Improving Physician Patient Communication. November 18, 2019 (1.0 FD)
• Just in Time Teaching in a Group Teaching Environment. December 26, 2019. (1.0 FD)

FY 2018

• Sleep Deprivation/Fatigue. OBGYN Grand Rounds. January 31, 2018
• IAMSE Webinar Series: Winter 2018. Continuity, LICs and Competency-based Education. February 6, 2018
• IAMSE Webinar Series: “Are You Leaving Too?  Combatting Burnout” by Tom Cox. August 2018
• IAMSE Webinar Series: Clarifying Expectations and Providing Feedback by Tom Cox. August 28, 2018
• IAMSE Webinar Series: How to Present and Summarize a Scientific Journal Article by Tom Cox. October 25, 2018
• Course: EGR Presentation: Professionalism and the Learning Environment. October 30, 2018
• Professionalism in Medicine. December 5, 2018.
• Teaching with Questions. December 10, 2018.
• Understanding Personality and Conflict Style. December 10, 2018.

Selected Academic Mentees (direct reports)

• Melody Sherwood MD – (fellow trainee/mentee 2015-2016), Faculty, Advanced Heart Failure and Transplant Cardiology, Baylor Scott & White Health, Dallas, Texas
• Luke Cunningham MD – (fellow trainee/mentee 2016-2017), Advanced Heart Failure and Transplant Cardiology, Baptist Integris Health, Oklahoma City
• Timothy Gong MD – (fellow trainee/mentee 2017-2018), Section Physician Leader, Advanced Heart Failure and Transplant Cardiology, HealthTexas Provider Network, a part of Baylor Scott & White Health, Adjunct Assistant Professor, Texas A&M Health Science Center
• Aasim Afzal, MD, MBA – (fellow trainee/mentee 2018-2019), Medical Director, Advanced Heart Failure, Baylor Scott & White Health – The Heart Hospital, Plano, Texas, Adjunct Assistant Professor, Texas A&M Health Science Center
• Vikram Raje, MD – (fellow trainee/mentee 2018-2019), Advanced Heart Failure and Transplantation Cardiology, Interventional Cardiology, Georgia Heart Institute
• Lieutenant Commander Joshua “Bear” Coney, MD – (fellow trainee/mentee 2019-2020), Director of Advanced Heart Failure and Transplant Cardiology, Tidelands Health, Associate Professor, Medical University of South Carolina
• Amit Alam MD – (fellow trainee/mentee 2019-2020), Faculty, Advanced Heart Failure and Transplant Cardiology, Baylor Scott & White Health, Dallas, Texas
• Ahmed Saliem MD – (fellow trainee/mentee 2019-2020), Faculty, Advanced Heart Failure and Transplant Cardiology, Loma Linda, California
• Venugopal Bhattad MD – (fellow trainee/mentee 2020-2021), Interventional Fellow, Boston University
• Nishi Patel MD – (fellow trainee/mentee 2020-2021), Advanced Heart Failure Cardiologist, WellSpan, York, Pennsylvania
• Arpan Patel MD – (fellow trainee/mentee 2020-2021), Advanced Heart Failure Cardiologist, Penn Medicine, Lancaster Pennsylvania
• Susan M Joseph, MD (mid-career/faculty mentee 2016-2020), Chief, Advanced Heart Failure and Transplant Cardiology University of Maryland Baltimore County
• Sandra Carey ACNP, PhD, Advanced Heart Failure and Transplant Cardiology Nurse Practitioner, Baylor University Medical Center, Dallas and Senior Scientist, CareDx (both current)
• HeartPlace / Dr. Shelley Hall on Congestive Heart Failure (CHF). https://www.youtube.com/watch?v=pXm2ZYSP-2w
• Shelley Hall - Living with Heart Failure (Part 1 of 2) – 2017. https://www.youtube.com/watch?v=VFFznISu0rQ
• ​Dr. Shelley Hall - Living with Heart Failure (Part 2 of 2) – 2017. https://www.youtube.com/watch?v=M-fJ_kEXxIc

 

BOARD CERTIFICATIONS:

• Cardiovascular Disease (Board-Eligible)
• Echocardiography (Board-Eligible)
• Nuclear Cardiology (Board-Eligible)
• Cardiovascular Computed Tomography (Board-Eligible)
• Internal Medicine

HOSPITALS:

• Texas Health Heart & Vascular Hospital
• Texas Health Arlington Memorial Hospital

EDUCATION:

• Fellowship, Cardiology: UT Southwestern, Dallas, TX
• Residency, Internal Medicine: UT Southwestern, Dallas, TX
• Internship, Internal Medicine: UT Southwestern, Dallas, TX
• Medical School, MD Degree: Emory University School of Medicine, Atlanta, GA
• Graduate, Master of Public Health, Epidemiology: Rollins School of Public Health, Atlanta, GA
• Undergraduate, Bachelor of Science Biochemistry/BA Classics (Summa Cum Laude): Hofstra University, Hempstead, NY

PROCEDURAL SKILLS:

• Transthoracic and transesophageal echocardiograms
• Cardiac stress tests
• Cardiac CT angiography
• Cardiac CT structural imaging

LEADERSHIP & VOLUNTEER ACTIVITIES:

• Session Leader: Led medical student small group sessions teaching cardiology skills, including EKG interpretation and echocardiography performance (2021–Present)
• Orientation Coordinator: Organized a dozen orientation lectures for incoming cardiovascular disease fellows (2021)
• Writer: Contributed to bi-monthly primary literature evaluation of Journal Watch, a resident-led online journal (2017–2019)
• Editor: Served as editor to bi-monthly primary literature evaluation of Journal Watch, a resident-led online journal (2019–2020)   

PUBLICATIONS/MEDIA:

Presentations & Abstracts ​

• Hoeting, N, Ayers, C, Rohatgi, A. “Deep Phenotyping of HDL Particles: Characterization of Seven HDL Species and Their Relationship to Cardiometabolic Phenotypes in a Multi-Ethnic Population”. Dallas Heart Study. 2018. Abstract accepted and poster presented at Arteriosclerosis, Thrombosis, and Vascular Biology. Presented at Seldin Symposium and UT-Southwestern/Turner Health Regional Cardiovascular Symposium. Selected to present at North Texas ACP competition.

 

• Hoeting, N, Oster, M. “Systolic Ejection Click vs. Split S1: Are Our Ears Deceiving Us?” Abstract accepted for oral presentation at American Academy of Pediatrics annual meeting, October 2016.

 

• Hoeting, N. “Pre-operative Clearance: A Risky Business”.  January 2022.

 

• Hoeting, N. “Racial and Social Determinants of Health in the Congenital Heart Disease Population". April 2021.

​

Research

• Analyzed coronary artery calcium on CT scans to improve cardiac preventative care across multiple centers. Developed analysis plan; first author on manuscript. July 2022–2023.

 

• Collaborated with internal medicine residents to establish a standardized echocardiography teaching curriculum; led didactics and hands-on sessions. August 2022–2023.

 

• Created medical education initiative to expand and standardize echocardiography curriculum for cardiology fellows. Selected dozens of high-quality echocardiography exams for a foundational lecture series. January 2022–2023.

 

• Analyzed Dallas Heart Study using novel Liposcience algorithm for improved characterization of HDL particle sizes. Abstract written and presented at multiple research meetings in 2018. November 2017–June 2019.

 

Get Medical Records From Dr. Singh's Previous Office

BOARD CERTIFICATIONS:

• Cardiovascular Disease
• Nuclear Cardiology
• Echocardiography
• Cardiac CT (pending)

LANGUAGES:

• English
• Hindi
• Punjabi

HOSPITALS:

• Baylor Scott & White Heart and Vascular Hospital - Dallas
• Baylor University Medical Center
• Hunt Regional Medical Center
• Texas Health Rockwall

EDUCATION:

• MBA, Graduated with Honors: University of Texas at Dallas Naveen Jindal School of Business, Dallas, TX
• Fellowship, Heart Failure/Transplant Hospitalist: Division of Cardiology, University of Washington Medical Center, Seattle, WA
• Fellowship, Cardiovascular Medicine: SUNY, Buffalo, NY
• Residency, Internal Medicine: University of Washington Medical Center, Seattle, WA
• Internship, Internal Medicine: University of Washington Medical Center, Seattle, WA
• Medical School, MD Degree: University of Washington School of Medicine, Seattle, WA
• Undergraduate: Bachelor of Science in Biology, with Honors, University of Puget Sound, Tacoma, WA

PROFESSIONAL APPOINTMENTS:

• Member: Quality and Safe Committee - Baylor Heart and Vascular Hospital (2014-present)
• Director: Hunt Regional Hospital Cardiac Cath Lab (2012-2014)
• Partner: Cardiology Consultants of Texas, Dallas, TX (2014-present)
• Member: Quality Assurance Committee - Buffalo Medical Group (2010-2012)
• Assistant Professor: University of Rochester Medical Center (2008-2011)

HONORS/AWARDS:

• Chief Cardiology Fellow - SUNY Buffalo Cardiology Fellowship (2006-2007)
• Nominated for Best Resident Teacher Award by medical students as residents (2002)
• Elected UW Alumni Representative for class 2001 - University of Washington School of Medicine (2001)
• Klea Bartirakas Award - Western Regional Medical Student Research Forum, Carmel, CA, Best Oral Presentation out of over 400 medical students from all over North America (2000)
• Best Oral Research Presentation, National Student Research Forum, Galveston, TX - In Epidemiology and Infectious Diseases for AIDS project in North India (1999)
• Elected Medical Student Association (MSA) Class Secretary (1999)

PROCEDURES:

• EKG
• Echocardiography
• Nuclear Stress Testing
• Arterial & Venous Extremity Dopplers / ABIs
• Arrhythmia Monitoring
• Coronary Calcium Scoring & Coronary CTA
• Cardiac MRI & MRI

SERVICES:

• Chest Pain
• Atrial Fibrillation
• Hypertension
• Congestive Heart Failure
• Peripheral Arterial Disease
• Stress Testing
• Coronary Artery Disease
• Weight Loss

BOARD CERTIFICATIONS:

• Interventional Cardiology
• General Cardiology

HOSPITALS:

• Medical City Plano
• Texas Health Allen
• Texas Health Frisco
• Texas Health Plano

EDUCATION:

• Fellowship, Interventional Cardiology: Baylor College of Medicine, Houston, TX
• Fellowship, Cardiovascular Disease: Baylor College of Medicine, Houston, TX
• Residency, Internal Medicine:  Baylor College of Medicine, Houston, TX
• Medical School, MD Degree:  Medical College of Virginia, Virginia Commonwealth, Richmond, Virginia 
• Graduate School, Masters of Science in Physiology Degree:  Medical College of Virginia, Virginia Commonwealth, Richmond, Virginia
• Undergraduate, Bachelors of Science in Biology Degree (Departmental Honors): Mary Washington College, Fredericksburg, Virginia 

PROCEDURAL SKILLS:

• Complex Coronary & Peripheral Interventions
• Heart Catheterizations
• Percutaneous Support Devices (Impella, IABP)
• Venous Reflux Disease & Ablation Therapy
• TAVR

PUBLICATIONS/MEDIA:

Publications:

• Brown WR, Levine, G. “Chest Pains and Angina”. In Levine, G, Cardiology Secrets (4th , pp. 110-116). Philadelphia, PA: Elsevier Saunders. (2014).

 

• Salloum FN, Abbate A, Houser J, Mudrick C, Roy S, Brown WR, Qureshi I, Prabhakar S and Kukreja R. “Sildenafil (Viagra) Attenuates Ischemic Cardiomyopathy and Improves Left Ventricular Function in Mice”. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1398-406. Epub. Jan 25, 2008.

 

• Majid M, Brown WR, Divakaran V, Virani S. “Pulmonic Valve Endocarditis, A Case Report.” Submitted to Texas Heart Inst Journal.

 

• Divakaran VG, Brown WR, Virani S. “Images in Echocardiography: A Freely Floating Saphenous Vein Graft.” Echocardiography. Vol 26. Aug, 2009.

 

• Brown WR. Assisted Drs. R. Kukreja and F. Salloum in the investigation of PDE-5 inhibitors and their role in cardio protection. “Chronic Inhibition of PDE-5 with Sildenafil (Viagra) Attenuates Ischemic Cardiomyopathy and Improves Left Ventricular Function in Mice”. 2007.

 

• Brown WR. Worked with Dr. T. Duane (Trauma Surgery) in the Medical College of Virginia Emergency Department. This research considered the value of pelvic/cervical spine films, and outcomes in various patient populations, including the obese and the diabetic patient. “The Role and Influence of Plain Films and Patient Demographics on Outcomes in the Trauma Bay." 2006.

 

• Brown WR. Worked with Dr. J. Feher to complete a thesis in physiology research. “Continuous Chemiluminescent Measurement of Superoxide in Intact Rat Hearts During Ischemia-Reperfusion.” 2002-2003.

 

• Brown WR. As a candidate for Biology departmental honors, worked with Dr. K. Loesser to complete a thesis in biological research. In May of 2001, presented research to the Virginia Academy of Science. The work subsequently appeared in the Academy’s publication. “Vitamin E: Efficacy of Gamma-Tocopherol vs. Alpha-Tocopherol in Atherosclerosis Prevention.” 2000-2001.

 

Poster Presentations:

• Oliver PA, Brown WR, Regan C, Stoltzfus J, Ornato JP. “Correlation Between Heart Rate in Pre-Hospital Patients In Atrial Fibrillation With Rapid Ventricular Response And Blood Serum Magnesium Levels”. AAEM meeting, Las Vegas, NV. Feb 2010.

 

• Salloum F, Abbate A, Brown WR, Hoke N, Kukreja RC. “Phosphodiesterase Inhibitors Reduce Myocardial Infarction, Apoptosis and Improve Post Ischemic Ventricular Function in Female Mice”. ACC meeting, Chicago, IL. March, 2008.

Ramon (Ray) Kumar, M.D., is board-certified in cardiovascular disease and interventional cardiology. He specializes in coronary artery disease, peripheral vascular disease, congestive heart failure, palpitations, and valve disease. Dr. Kumar practices at HeartPlace Allen, Texas, where he is committed to providing the highest quality of care to his patients.

Dr. Kumar earned his Doctor of Medicine degree at UT Southwestern in Dallas, Texas. He completed his residency in internal medicine at Harvard Medical School/Beth Israel in Boston, Massachusetts, followed by multiple fellowships at the prestigious Texas Heart Institute in Houston, Texas.

Dr. Kumar has long served as a leader in the field of cardiology. His extensive experience includes directing catheterization labs and serving as STEMI Director in multiple healthcare systems, ensuring optimal care for acute heart attack patients. With his expertise in peripheral vascular interventions, complex coronary revascularization, and valve disease procedures, Dr. Kumar often manages challenging cases referred from across Texas and beyond.

Dr. Kumar’s dedication to his patients stems from a personal commitment to treating each individual like family, inspired by his own experiences. Outside of his medical practice, Dr. Kumar enjoys spending time with his wife and three children, weightlifting, swimming, playing pickleball, and exploring physics and philosophy.

BOARD CERTIFICATIONS:

• Cardiovascular Disease
• Interventional Cardiology

EDUCATION:

• Fellowship, Interventional Cardiology: Texas Heart Institute, Houston, TX
• Residency, Internal Medicine: Harvard Medical School/Beth Israel, Boston, MA
• Medical School, MD Degree: UT Southwestern, Dallas, TX

HONORS & AWARDS:

• Outstanding Resident Teacher Award, Harvard Medical School
• Chief Interventional Fellow, Texas Heart Institute

OFFICE LOCATION:

HeartPlace Allen
1105 N. Central Expy., Bldg. 2 Ste. 2330
Allen, TX 75013

Office: 972-649-6511

Fax: 844-290-4360